Radiation Advisory Committee Annual Report ... - health.vic.gov.au
Radiation Advisory Committee Annual Report ... - health.vic.gov.au
Radiation Advisory Committee Annual Report ... - health.vic.gov.au
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
i<br />
THE ANNUAL REPORT OF<br />
THE RADIATION ADVISORY COMMITTEE<br />
FOR THE YEAR ENDING SEPTEMBER 1998
RADIATION ADVISORY COMMITTEE<br />
Melbourne Australia<br />
© State of Victoria 1998<br />
ISSN 1035-7912<br />
This document is also available electronically at:<br />
http://www.dhs.<strong>vic</strong>.<strong>gov</strong>.<strong>au</strong>/phd/hprot/rsu/98report/index.htm<br />
ii
RADIATION ADVISORY COMMITTEE<br />
The Honourable Rob Knowles, MP<br />
Minister for Health<br />
Dear Minister,<br />
iii<br />
Pursuant to Section 108AK(10) of the Health Act 1958, the <strong>Radiation</strong> <strong>Advisory</strong> <strong>Committee</strong> submits the 1998<br />
<strong>Annual</strong> <strong>Report</strong> of the <strong>Committee</strong> for presentation to Parliament.<br />
Yours faithfully,<br />
B M Tress<br />
(Professor)<br />
Chairman<br />
RADIATION ADVISORY COMMITTEE
CONTENTS:<br />
THE RADIATION ADVISORY COMMITTEE<br />
1<br />
PAGE NO.<br />
Composition 4<br />
Responsibilities 7<br />
1. IONIZING RADIATIONS<br />
1.1 RACR Accreditation Guidelines and Quality Assurance <strong>Committee</strong> 8<br />
1.2 Research on Genomic Instability 8<br />
1.3 Yttrium 90 Guidelines 8<br />
1.4 <strong>Radiation</strong> Safety Unit Project <strong>Report</strong>s 8<br />
1.5 Research Involving <strong>Radiation</strong> Exposure of Human Volunteers 9<br />
and Informed Consent for such Research<br />
1.6 Requirements for Transport of Radioactive Material 9<br />
1.7 Radiotherapy to Prevent Restenosis 9<br />
1.8 Formation of Australian <strong>Radiation</strong> Protection and Nuclear Safety Agency (ARPANSA) 9<br />
1.9 Standards for CT Scanning Equipment 9<br />
1.10 Use of Image Intensifiers in Theatre, Alfred Hospital 10<br />
1.11 Orthopaedic Surgeon - Request for Extension to Licence 10<br />
1.12 Wemen Mineral Sands Project, RZM 10<br />
1.13 Radon in Underground Caves 10<br />
1.14 National Framework for <strong>Radiation</strong> Protection and Control 10<br />
1.15 Registration of CT Scanner at Berwick, VIG 10<br />
1.16 Australian Institute of Radiography Concern about Registration of Equipment 11<br />
1.17 Request to Licence Anaesthetist, Dr Harrison, Maryvale Private Hospital 11<br />
1.18 Thyroid Doses to Orthopaedic Surgeons 11<br />
1.19 Licensing of Orthopaedic Registrars, Western Hospital - Sunshine 11<br />
1.20 Request for Licence to Operate Fluoroscan Image Intensifier - Mr David Maruskanic 11<br />
1.21 Request for Licence to Operate Bone Mineral Densitometer - Ms B Mitchell 11<br />
1.22 Proposal for Iodine 125 Treatment of Prostatic Cancer - EMROC 11<br />
1.23 Numbers of Licences and Registrations Issued 11
1.24 <strong>Radiation</strong> Safety Testing 11<br />
1.25 Training Courses in <strong>Radiation</strong> Safety 12<br />
1.26 Request for Exemption from Personal Monitoring 12<br />
1.27 Use of Samarium 153 12<br />
1.28 Need for Teleradiology Guideline 12<br />
1.29 Use of Iodine 131 for Treatment of Hyperthyroidism in Cats 12<br />
1.30 National Radioactive Waste Repository 12<br />
1.31 CT Scanner Registration Conditions - Swan Hill Hospital 13<br />
1.32 Use of Image Intensifiers by Unlicensed Persons - Royal Melbourne Hospital 13<br />
1.33 Department Store for Obsolete Radioactive Materials 13<br />
1.34 Course on Radiography for General Practitioners 13<br />
1.35 Application for Operator Licence, Ms Paton, Upper Murray Health & Community Ser<strong>vic</strong>es 13<br />
1.36 Request for Examination in Cambodian Language 13<br />
1.37 Application to Operate Image Intensifier, Mr W Straffon, Urologist, Maryvale Private Hospital 13<br />
1.38 Exemption from Licence to Store X-ray Equipment 14<br />
1.39 Application of CT Code to Radiotherapy Treatment Planning CT Scanners 14<br />
1.40 Request for Exemption from Licensing Examination - Mr F Bove 14<br />
1.41 Approval for Rapiscan Secure 1000 14<br />
1.42 Review of Health Act 1958 14<br />
1.43 CT Scanner Installation, Gippsland Diagnostic Ser<strong>vic</strong>es 14<br />
1.44 <strong>Radiation</strong>-Wise Personal Monitoring Ser<strong>vic</strong>e 14<br />
1.45 Other Matters Considered 14<br />
2. RADIOGRAPHY IN GENERAL PRACTICE<br />
2.1 Introduction 16<br />
2.2 Membership 16<br />
2.3 Issues Discussed by Working Party 16<br />
2.4 Summary of Working Party Discussions 16<br />
3. NON-IONIZING RADIATION<br />
3.1 Papers Considered in the Past 12 Months Related to Biological Effects from Exposure<br />
to Power Frequency Electromagnetic Fields 17<br />
2
3.2 Papers Considered in the Past 12 Months Related to Biological Effects from Exposure<br />
to Radiofrequency <strong>Radiation</strong> 19<br />
3.3 The <strong>Committee</strong>'s View on the Health Effects of Electromagnetic Fields 20<br />
3.4 The <strong>Committee</strong>'s View on the Health Effects of Radiofrequency <strong>Radiation</strong> 20<br />
3.5 Review of Physiotherapists Act 20<br />
3.6 Review of Need for Non-ionizing <strong>Radiation</strong> Controls 20<br />
3.7 <strong>Radiation</strong> Health <strong>Committee</strong> Statement on Hair Depilation Lasers 20<br />
3.8 Operation of Medical Lasers, Dr Garth Dicker 21<br />
4. RADIATION INCIDENTS<br />
4.1 Damage to a Nuclear Moisture/Density G<strong>au</strong>ge 22<br />
4.2 Transport Incident - Wards Transport 22<br />
4.3 Industrial Radiography - Employee Enters Radiography Area - Tenix 23<br />
4.4 Disposal of Gas Chromatograph Source - Centre for Forest Tree Technology 23<br />
4.5 Industrial Radiography Incident - Australian NDT Ser<strong>vic</strong>es P/L 23<br />
4.6 Transport Incident - Bresatec P/L 24<br />
4.7 Misadministration of Radiopharmaceuticals - Alfred Hospital 24<br />
4.8 Hair Loss Following Neuroradiology 25<br />
4.9 Iodine 131 Dose to Pregnant Woman - Monash Medical Centre 25<br />
5. APPENDICES<br />
Appendix I: Summary of Doses Measured in Patient Dose Surveys 26<br />
Appendix II: Guidance Dose Levels Recommended for Use in Victoria 28<br />
Appendix III: Research with Human Volunteers -- Projects Approved 29<br />
Appendix IV: (a) Numbers of Operator Licences as at 21 Sep 1998 30<br />
(b) Numbers of Registrations as at 21 Sep 1998 31<br />
(c) Numbers of Management Licences as at 21 Sep 1998 32<br />
Appendix V: Summary of <strong>Radiation</strong> Safety Testing -- May 1984 to September 1998 33<br />
Appendix VI Summary of Training Courses and Examinations in <strong>Radiation</strong> Safety 34<br />
Appendix VII: Papers Related to Biological Effects Associated with Power Frequency<br />
Electromagnetic Fields Considered in the Past Year<br />
35<br />
Appendix VIII Summary of Epidemiology Papers (1997-1998) 39<br />
Appendix IX Papers Related to Biological Effects Associated with Radiofrequency<br />
<strong>Radiation</strong> Considered in the Past Year<br />
39<br />
7. ABBREVIATIONS 40<br />
3
THE RADIATION ADVISORY COMMITTEE<br />
The <strong>Radiation</strong> <strong>Advisory</strong> <strong>Committee</strong> met on 11 occasions from October 1997 to September 1998.<br />
Composition<br />
Members of the <strong>Radiation</strong> <strong>Advisory</strong> <strong>Committee</strong> were: Meetings Attended<br />
Professor Brian M. Tress Chairman 8<br />
Head<br />
Department of Radiology<br />
University of Melbourne<br />
Dr. Keith H. Lokan Member 4<br />
Director (Resigned April 1998)<br />
Australian <strong>Radiation</strong> Laboratory<br />
Dr. John C.P. Heggie Member 10<br />
Director<br />
Department of Medical Engineering & Physics<br />
St Vincent's Hospital<br />
Dr. Michael J. Kelly Member 9<br />
Director of Nuclear Medicine<br />
Alfred Hospital<br />
4
Mr. Ken Bennetts Member 5<br />
Chief Radiographer<br />
Northern Hospital<br />
Dr. Andrew W. Wood Member<br />
Senior Lecturer in Biophysics<br />
School of Biophysical Sciences and Electrical Engineering<br />
Swinburne University of Technology<br />
Mr. F.P.J.(Rob) Robotham<br />
<strong>Radiation</strong> Safety Consultant<br />
Dr. Graham J. Rouch<br />
Chief Health Officer<br />
Department of Human Ser<strong>vic</strong>es<br />
Dr Andrew Wirth<br />
Staff Specialist in <strong>Radiation</strong> Oncology<br />
Peter MacCallum Cancer Institute<br />
5<br />
Member 11<br />
Member 9<br />
Member 6<br />
9
Dr Malcolm Sim Member 3<br />
Senior Lecturer & Head<br />
Unit of Occupational & Environmental Health<br />
Department of Epidemiology & Preventive Medicine<br />
Monash University<br />
Mr Peter Burns Member 3<br />
Head, Scientific Ser<strong>vic</strong>es Section (Appointed 22/5/1998)<br />
Australian <strong>Radiation</strong> Laboratory<br />
Ms Caroline Isakow Secretary<br />
<strong>Radiation</strong> Safety Unit<br />
Department of Human Ser<strong>vic</strong>es<br />
6
Responsibilities<br />
7<br />
The <strong>Radiation</strong> <strong>Advisory</strong> <strong>Committee</strong> was established by the Minister for Health under the Health Act 1958 (as amended) to advise the<br />
Minister or the Chief General Manager on any matters relating to the administration of the radiation legislation referred to it by the<br />
Minister or the Chief General Manager including the following:<br />
(a) the promotion of radiation safety procedures and practices;<br />
(b) recommending the criteria for the licensing of persons and the qualifications, training or experience required for<br />
licensing;<br />
(c) recommending the criteria for the registration of radiation apparatus and sealed radioactive sources;<br />
(d) recommending the nature, extent and frequency of periodic safety assessments of radiation apparatus and sealed<br />
radioactive sources;<br />
(e) codes of practice with respect to particular radioactive substances and uses of ionizing and non-ionizing radiation;<br />
and<br />
(f) any matter which the Minister agrees the <strong>Committee</strong> should consider and report on.
1. IONIZING RADIATIONS<br />
1.1 RACR Accreditation Guidelines and<br />
Quality Assurance <strong>Committee</strong><br />
The <strong>Committee</strong> received copies of the draft Royal<br />
Australasian College of Radiologists (RACR)<br />
Accreditation Guidelines for comment. The <strong>Committee</strong><br />
noted that the draft guidelines were at an early stage of<br />
development and welcomed the opportunity to contribute<br />
to those areas of the guidelines which related to radiation<br />
safety. Comments were forwarded to RACR along with<br />
an offer to contribute to further drafts as the guidelines are<br />
developed.<br />
1.2 Research on Genomic Instability<br />
The <strong>Committee</strong> received an article from New Scientist, 11<br />
Oct 1997 edition which reported on research in the UK<br />
which claims that radiation damages DNA in a new and<br />
unexpected way which has been called genomic<br />
instability. The National <strong>Radiation</strong> Protection Board of<br />
the UK has refuted the interpretation of the research.<br />
NRPB have stated that there is no proof that genomic<br />
instability leads to cancer or other diseases, no studies that<br />
have shown an association between illness and instability<br />
and there is no hard evidence of any c<strong>au</strong>sal mechanisms.<br />
Even if instability c<strong>au</strong>ses an increased rate of illness, it<br />
would already be taken into account by existing safety<br />
limits. The <strong>Committee</strong> will continue to review any further<br />
information on research in this area.<br />
1.3 Yttrium 90 Guidelines<br />
The <strong>Committee</strong> had previously recommended<br />
establishment of a working party to examine the need for<br />
development of guidelines for the use of yttrium 90 in<br />
radiation synovectomies. It was reported that the working<br />
party:<br />
Dr Michael Kelly (RAC, ANZAPNM)<br />
Mr B van Every (ANZSNM)<br />
Dr J Findeison (ARA)<br />
Dr G Klempfner (RACR)<br />
Mr A Melbourne (RSU)<br />
Ms I Cardillo (RSU)<br />
had now met and considered that there would be value in<br />
producing guidelines. The working party discussed the<br />
various arrangements used for this procedure at different<br />
institutions and the safety and training issues involved.<br />
Work on a draft guideline has commenced. Progress will<br />
be reported to the <strong>Committee</strong>.<br />
1.4 <strong>Radiation</strong> Safety Unit Project <strong>Report</strong>s<br />
The <strong>Committee</strong> received reports from the <strong>Radiation</strong><br />
Safety Unit on a number of patient dose surveys being<br />
conducted. The patient dose projects included surveys of:<br />
1. Paediatric Doses from Diagnostic Radiology<br />
8<br />
A draft report on the completed survey was provided for<br />
comment and adoption of the recommended guidance<br />
dose levels.<br />
2. Survey of Fluoroscopic Units in Victoria<br />
A draft of the completed survey was discussed along with<br />
a request for ad<strong>vic</strong>e from the <strong>Radiation</strong> Safety Unit on the<br />
need for further data to be collected using dose-area<br />
product meters, and a recommendation to adopt the<br />
guidance levels developed from the survey data. The<br />
<strong>Committee</strong> agreed to the adoption of the guidance levels<br />
and did not feel that a DAP survey would be<br />
advantageous.<br />
In line with the recommendations of the International<br />
Commission on Radiological Protection (ICRP) and the<br />
NHMRC in Australia, the <strong>Committee</strong> has now approved<br />
the introduction of guidance dose levels for paediatric<br />
radiology, fluoroscopy examinations, adult chest (PA) and<br />
general radiography, neonate chest (AP), chiropractic, and<br />
CT Scanning. The guidance levels have been set at the<br />
third quartile level found in the patient dose studies<br />
referred to above. A summary of the guidance levels<br />
recommended for use in Victoria is presented in Appendix<br />
II along with a summary of the doses measured in this<br />
year’s surveys in Appendix I. Guidance levels are<br />
intended to provide an indication of doses for average<br />
sized patients; to provide guidance on what is achievable<br />
with current good practice, rather than what should be<br />
considered to be optimum performance; to be applied with<br />
flexibility to allow higher exposures if they are indicated<br />
by sound clinical judgement; and to be revised as<br />
technology and techniques are improved. Centres with<br />
doses that are higher than the guidance level are asked to<br />
review their radiography practices in order to reduce the<br />
patient dose to less than the guidance level.<br />
A progress report on a survey in Mammography, and a<br />
final report on Radon in Caves were also presented.<br />
The <strong>Committee</strong> commended the <strong>Radiation</strong> Safety Unit on<br />
the high standard of the projects completed and of those in<br />
progress.<br />
The <strong>Radiation</strong> Safety Unit also presented a proposal for<br />
further research projects to be undertaken. These<br />
included:<br />
Adult Radiography Procedures<br />
General Practitioner Chest Radiography<br />
Interventional Radiology<br />
Thyroid Doses to Orthopaedic and other Surgeons<br />
It was also proposed to produce an information pamphlet<br />
for industrial radiographers, update the ELF public<br />
information document, review the level of compliance<br />
with notification of sales conditions and complete work on<br />
X-ray testing protocols and accreditation of private testers<br />
which was in progress.
The <strong>Committee</strong> approved the proposed program and noted 1.6 Requirements for Transport of<br />
that there were additional projects being developed for Radioactive Material<br />
consideration on completion of those currently proposed.<br />
A progress report on the general practitioner chest survey<br />
was discussed. A survey had been sent to those general<br />
practitioners approved to take chest X-rays. In view of<br />
the ad<strong>vic</strong>e resulting from the survey the <strong>Committee</strong><br />
recommended that all general practitioners approved for<br />
chest X-rays should be included in the survey even if no<br />
response to the survey had been provided.<br />
1.5 Research Involving <strong>Radiation</strong><br />
Exposure of Human Volunteers and<br />
Informed Consent for such Research<br />
During the year the <strong>Committee</strong> reviewed 30 new or<br />
continuing research projects. Research projects involving<br />
radiation exposure of human volunteers requires approval<br />
from both the institution's Ethics <strong>Committee</strong> and the<br />
Department of Human Ser<strong>vic</strong>es. Institutions proposing to<br />
undertake such research must provide copies of the<br />
research protocol, patient information sheet, radiation<br />
dose estimate, and evidence of approval by the<br />
institution's Ethics <strong>Committee</strong>. This information is<br />
reviewed by the <strong>Committee</strong> before recommendations<br />
approving the research are made.<br />
In a number of cases the <strong>Committee</strong> requested revised or<br />
more detailed dose estimates or revision to the patient<br />
information sheet statements on risk prior to approving the<br />
research.<br />
The 21 projects approved by the <strong>Committee</strong> are listed in<br />
Appendix III.<br />
Nine of the 30 projects involved patients, where a<br />
potential direct benefit to the individual would apply. The<br />
<strong>Committee</strong> was of the view that these projects should be<br />
treated as medical management rather than volunteer<br />
research.<br />
Discussion on a number of the projects raised the issue of<br />
what information on radiation risks should be required to<br />
be included in volunteer/patient information in order to<br />
obtain informed consent. The <strong>Committee</strong> reviewed a<br />
number of articles on this subject and arranged for Ms<br />
Bebe Loff, Monash Medical School, Epidemiology Unit<br />
to address the <strong>Committee</strong>. As a result of the discussion<br />
the <strong>Committee</strong> decided that it needed to develop a<br />
guidance document for ethics committees which provided<br />
ad<strong>vic</strong>e on the type of information that should be included<br />
in volunteer information sheets for research involving<br />
radiation exposure of humans.<br />
The <strong>Committee</strong> also received a copy of an NHMRC<br />
Draft Statement on Ethical Conduct in Research<br />
Involving Humans for comment. It was noted that the<br />
document did not contain any reference to research<br />
involving radiation exposure of volunteers. The<br />
<strong>Committee</strong> recommended that a response to NHMRC<br />
which raised this issue be prepared.<br />
9<br />
The <strong>Committee</strong> reviewed the arrangements for applicants<br />
to obtain a licence to transport radioactive materials.<br />
Currently applications are individually assessed and a<br />
three hour training course is offered. In light of recent<br />
incidents the need for examination of applicants prior to<br />
issuing a licence was considered. The <strong>Committee</strong><br />
recommended that a compulsory training course be<br />
adopted in preference to an examination.<br />
1.7 Radiotherapy to Prevent Restenosis<br />
A letter was received from the Royal Australasian College<br />
of Radiologists advising of the development of techniques<br />
using radiotherapy to prevent restenosis following<br />
angioplasties. Concern was expressed about the potential<br />
radiation safety issues involved and the need for adequate<br />
training of those involved in the technique. <strong>Committee</strong><br />
members and <strong>Radiation</strong> Safety Unit staff will seek further<br />
information on the techniques being used. It was noted<br />
that the techniques were still only used in clinical research<br />
studies subject to ethical controls and review of radiation<br />
doses.<br />
1.8 Formation of Australian <strong>Radiation</strong><br />
Protection and Nuclear Safety Agency<br />
(ARPANSA)<br />
The <strong>Committee</strong> received a press release from The Hon.<br />
Trish Worth, Parliamentary Secretary to the Minister for<br />
Health and Family Ser<strong>vic</strong>es announcing the formation of<br />
ARPANSA a new regulatory agency which will control<br />
the Commonwealth’s radiation and nuclear activities. It<br />
was noted that ARPANSA will also work with the States<br />
and Territories to promote uniform radiation <strong>health</strong> and<br />
nuclear safety policies and practices for all Australians.<br />
The formation of ARPANSA brings together the<br />
Australian <strong>Radiation</strong> Laboratory and the Nuclear Safety<br />
Bure<strong>au</strong>. The <strong>Committee</strong> welcomed announcement of the<br />
formation of ARPANSA and requested to be kept<br />
informed of progress.<br />
1.9 Standards for CT Scanning<br />
Equipment<br />
The <strong>Radiation</strong> Safety Unit reported that as a result of the<br />
survey of CT scanning equipment, there was a need to<br />
clarify the requirements of the CT Code of Practice in<br />
relation to 10 year old scanners. The Code requires that<br />
such scanners must produce images of ‘adequate<br />
diagnostic quality’ and meet radiation protection<br />
standards in order to continue operating. A scanner had<br />
been found with a Q-value (a measurement of dose<br />
efficiency and imaging performance parameters) below<br />
average for abdomen scans.
Figure 1. A CT scanner<br />
The <strong>Committee</strong> recommended that the proposed criteria<br />
for 10 year old scanners be discussed with the Royal<br />
Australasian College of Radiologists, as the College had<br />
been involved in development of the Code. The<br />
<strong>Committee</strong> felt that a sample of images may need to be<br />
reviewed by a panel of radiologists in addition to<br />
objective measurements. Discussions with the College<br />
have commenced and further ad<strong>vic</strong>e is being sought<br />
within the Department on the issues raised.<br />
1.10 Use of Image Intensifiers in Theatre,<br />
Alfred Hospital<br />
A request for ad<strong>vic</strong>e on licensing of persons to operate<br />
image intensifiers in theatre was received from the Alfred<br />
Hospital. The particular concern related to areas where<br />
one radiographer may be rostered to cover three theatres<br />
using image intensifiers. Consideration of licensing<br />
medical specialists and registrars after in-house radiation<br />
safety training was requested, along with a request for<br />
ad<strong>vic</strong>e on the need for a radiographer when a registrar was<br />
working. The <strong>Committee</strong> advised that a radiographer<br />
must be present when a registrar was working and that the<br />
proposed training for other medical staff was supported.<br />
1.11 Orthopaedic Surgeon - Request for<br />
Extension to Licence<br />
Mr M Thomas, Orthopaedic Surgeon had previously been<br />
granted a restricted licence to undertake limited<br />
procedures at Latrobe Regional Hospital. Mr Thomas<br />
requested approval for additional procedures using a<br />
different type of image intensifier and at an additional<br />
location, Maryvale Private Hospital. The <strong>Committee</strong><br />
sought further ad<strong>vic</strong>e on the equipment and additional<br />
procedures intended. The <strong>Committee</strong> recommended that<br />
the licence be extended to allow operation of the<br />
equipment at Maryvale Private Hospital but that the range<br />
of procedures permitted to be undertaken without a<br />
radiographer present not be extended.<br />
1.12 Wemen Mineral Sands Project, RZM<br />
A report was received from the <strong>Radiation</strong> Safety Unit on<br />
the proposed RZM mineral sand development at Wemen,<br />
near Robinvale. The report requested ad<strong>vic</strong>e on the need<br />
for RZM to be licensed for the project. The projected<br />
10<br />
doses were extremely low, and appeared to be below the<br />
10 microsievert per year level, above which the material<br />
could be declared radioactive. A draft document prepared<br />
by the <strong>Radiation</strong> Safety Unit in response to the<br />
Environment Effects Statement on the project was also<br />
reviewed by the <strong>Committee</strong>. It was agreed that no licence<br />
was necessary, however it was recommended that a<br />
representative of the <strong>Radiation</strong> Safety Unit be appointed<br />
to the Environmental monitoring <strong>Committee</strong>, and that the<br />
Unit reserve the option to require RZM to obtain a licence<br />
if measurements conducted in the environmental<br />
monitoring program on site demonstrate higher than<br />
predicted levels of radiation exposure.<br />
1.13 Radon in Underground Caves<br />
The <strong>Committee</strong> was provided with a research paper by<br />
<strong>Radiation</strong> Safety Unit officers on radon levels in Buchan<br />
caves. The <strong>Radiation</strong> Safety Unit also prepared a draft<br />
radiation management plans for both Buchan and Princess<br />
Margaret Rose cave systems and issues of personal<br />
monitoring versus area monitoring as the most appropriate<br />
means of assessing exposure of tour guides were<br />
discussed. It was proposed that consultation with Parks<br />
Victoria, Manager Buchan Caves, Manager Princess<br />
Margaret Rose Caves, and Workcover take place and their<br />
views be incorporated in the management plans. The<br />
<strong>Committee</strong> asked to be kept informed of the outcome of<br />
these discussions.<br />
1.14 National Framework for <strong>Radiation</strong><br />
Protection and Control<br />
The <strong>Committee</strong> discussed a letter forwarded to the<br />
Minister by The Hon. Trish Worth MP seeking<br />
endorsement of a report recommending the development<br />
of a uniform regulatory framework for the control of<br />
ionizing and non-ionizing radiation. The report had been<br />
prepared by Dr J McNulty as consultant, assisted by a<br />
reference group. It had been discussed during preparation<br />
by the national <strong>Radiation</strong> Protection Panel, of which Mr<br />
Melbourne of the <strong>Radiation</strong> Safety Unit is a member. The<br />
<strong>Committee</strong> supported the uniformity process and<br />
requested to be kept informed as it developed further. It<br />
was subsequently noted that a response endorsing the<br />
report but emphasizing matters for consideration, such as<br />
National Competition Policy, had been forwarded.<br />
1.15 Registration of CT Scanner at<br />
Berwick, VIG<br />
The <strong>Committee</strong> considered a proposal to register a CT<br />
scanner at VIG, Berwick. It was noted that the practice<br />
did not meet the requirements under the Code of Practice<br />
on CT scanning equipment in respect of the cl<strong>au</strong>se<br />
requiring that scanners only be installed in comprehensive<br />
practices as defined in the code. In view of the fact that<br />
the proposal did not meet the code the <strong>Committee</strong><br />
recommended that registration be refused. VIG<br />
subsequently arranged for an additional imaging modality<br />
to be installed at the practice to meet the code<br />
requirements and the registration was subsequently<br />
approved.
1.16 Australian Institute of Radiography<br />
Concern about Registration of<br />
Equipment<br />
The <strong>Committee</strong> received a letter from the Honorary<br />
Secretary of the Victorian Branch of the AIR suggesting<br />
that there were deficiencies in the Health Act in relation to<br />
registration requirements and fees, and that the Act does<br />
not specify periods for testing. The <strong>Committee</strong> noted that<br />
a number of registration fees were reduced in the 1994<br />
review of the Regulations, and that the Act gives power to<br />
the Secretary to set the test periods rather than set periods<br />
in the Act itself. The <strong>Committee</strong> requested that the<br />
<strong>Radiation</strong> Safety Unit reply to AIR.<br />
1.17 Request to Licence Anaesthetist, Dr<br />
Harrison, Maryvale Private Hospital<br />
The <strong>Committee</strong> received a request to licence Dr Grant<br />
Harrison, Anaesthetist to operate an image intensifier at<br />
Maryvale Private Hospital without a radiographer being<br />
present. The request was to assist in orthopaedic<br />
procedures, anaesthetic procedures (location of needle<br />
position in lumbar sympathectomy), and general surgical<br />
procedures. The <strong>Committee</strong> sought further information on<br />
the need for a licence, number of procedures, training, and<br />
overlapping with surgeons already holding licences. After<br />
considering the response provided the <strong>Committee</strong> did not<br />
believe that adequate justification had been provided and<br />
recommended that a licence not be issued.<br />
1.18 Thyroid Doses to Orthopaedic<br />
Surgeons<br />
Dr Heggie tabled a letter from the Australian Orthopaedic<br />
Association quoting preliminary research which suggests<br />
that orthopaedic surgeons have a high incidence of thyroid<br />
cancer attributable to radiation exposure. The letter<br />
sought to ensure that appropriate protective de<strong>vic</strong>es were<br />
provided for orthopaedic surgeons. The <strong>Committee</strong><br />
requested that further information be sought on the<br />
research quoted, and other literature in this area. It was<br />
noted that the <strong>Radiation</strong> Safety Unit had proposed to<br />
undertake a research project on the thyroid radiation doses<br />
of orthopaedic and other surgeons.<br />
1.19 Licensing of Orthopaedic Registrars,<br />
Western Hospital - Sunshine<br />
A letter was received from Western Hospital Sunshine<br />
requesting approval for orthopaedic registrars to be<br />
licensed to use image intensifier equipment after hours<br />
without a radiographer being present. The hospital did<br />
not wish to have to recall a radiographer to duty or have<br />
the surgeon present for simple procedures after hours.<br />
The <strong>Committee</strong> noted that registrars were not required to<br />
be licensed but must operate under the supervision of a<br />
licensed person. It was not considered appropriate that<br />
registrars operate equipment without either a radiographer<br />
or licensed surgeon being present. The hospital was<br />
advised that the proposal would not be approved.<br />
11<br />
1.20 Request for Licence to Operate<br />
FluoroScan Image Intensifier - Mr<br />
David Maruskanic<br />
Mr David Maruskanic, Director of Nursing, Sir John<br />
Monash Private Hospital requested approval to operate a<br />
FluoroScan imaging system during a trial period prior to<br />
purchasing. The <strong>Committee</strong> rejected the proposal by Mr<br />
Maruskanic as he has no radiation safety training. The<br />
<strong>Committee</strong> recommended that the hospital should hire a<br />
locum radiographer for the trial period.<br />
1.21 Request for Licence to Operate Bone<br />
Mineral Densitometer - Ms B Mitchell<br />
The <strong>Committee</strong> considered a request to licence Ms B<br />
Mitchell to operate a bone mineral densitometer at RMIT,<br />
Bundoora. Ms Mitchell is a qualified nurse however after<br />
seeking further detail on her background and experience,<br />
the <strong>Committee</strong> did not consider that Ms Mitchell had<br />
adequate radiation safety knowledge. It was<br />
recommended the a licence not be issued.<br />
1.22 Proposal for Iodine 125 Treatment of<br />
Prostatic Cancer - EMROC<br />
The <strong>Committee</strong> received a request for approval to use<br />
iodine 125 for the treatment of prostatic cancer, to be<br />
considered separately from a previous joint proposal to<br />
use either iodine 125 or manual afterloading of iridium<br />
192. The <strong>Committee</strong> approved the proposal subject to<br />
confirmation that the radiation levels outside patients’<br />
rooms would be satisfactory and that standard nuclear<br />
medicine protection techniques would be implemented.<br />
The <strong>Committee</strong> also recommended that a copy of the seed<br />
loading procedure be submitted to the <strong>Radiation</strong> Safety<br />
Unit.<br />
1.23 Numbers of Licences and<br />
Registrations Issued<br />
The <strong>Committee</strong> was provided with data from the<br />
<strong>Radiation</strong> Safety Unit's computer register of licences and<br />
equipment registrations issued under the Health<br />
(<strong>Radiation</strong> Safety) Regulations. The details are in<br />
Appendix IV.<br />
1.24 <strong>Radiation</strong> Safety Testing<br />
A letter was received from Mr Anthony Wallace of Austin<br />
& Repatriation Medical Centre regarding testing of X-ray<br />
equipment in relation to period of testing and potential<br />
conflict with Australian Standard AS/NZS 3551:1996.<br />
The <strong>Committee</strong> agreed that a letter be sent to Standards<br />
Australia raising issues of concern in AS/NZS 3551:1996.<br />
This Standard deals mainly with electrical safety but<br />
could also be interpreted as covering radiation safety<br />
testing. The concern is that the testing protocol<br />
implemented by the Standard may conflict with radiation<br />
safety regulatory requirements.
A summary of testing of currently registered equipment<br />
appears in Appendix V.<br />
1.25 Training Courses in <strong>Radiation</strong> Safety<br />
The <strong>Committee</strong> was advised that in the last 12 months, the<br />
<strong>Radiation</strong> Safety Unit had been involved in several<br />
radiation safety training courses for various occupational<br />
categories. These included groups involved with the use<br />
of g<strong>au</strong>ges in industry, and nuclear moisture/density g<strong>au</strong>ges<br />
(NMDG). ANSTO Training ran the courses with some<br />
lectures in each being provided by <strong>Radiation</strong> Safety Unit<br />
staff. The industrial radiography course was run by<br />
RMIT. A summary of the number of courses and<br />
attendees appears as Appendix VI.<br />
Following the industrial radiography training course held<br />
in May/June 1998 a <strong>Radiation</strong> Protection in Industrial<br />
Radiography examination was held. The <strong>Committee</strong> had<br />
previously recommended that this examination be passed<br />
by all industrial radiographers and applicants for licences<br />
in the industrial radiography field. People who had not<br />
attended the course were allowed the opportunity to sit the<br />
examination at other times during the year. A total of 7<br />
examinations were held between October 1997 and the<br />
end of September 1998. Further examinations were also<br />
held during the year for people requiring restricted<br />
licences to carry out industrial radiography and for people<br />
operating fixed enclosure X-ray apparatus.<br />
The first examination for operator licensing in the<br />
occupational category of nuclear moisture g<strong>au</strong>ge operator<br />
was held in May 1996. Since that time (up to October<br />
1998), there have been 278 passes from 327 candidatures.<br />
At the time of writing, there were 385 people licensed or<br />
applying for licence on the radiation register.<br />
Approximately 72% of licence holders/applicants have<br />
passed the Victorian examination. Other licensees may<br />
have passed an equivalent examination from interstate and<br />
are therefore exempt from the requirement to pass the<br />
Victorian examination. Details of the examinations held<br />
in 1997/98 and since inception in 1996 are included in<br />
Appendix VI.<br />
1.26 Request for Exemption from Personal<br />
Monitoring<br />
Dr Arnold Shmerling, general practitioner requested<br />
exemption from personal monitoring on the basis of low<br />
workload and low doses recorded over a period of time.<br />
The <strong>Committee</strong> did not approve the request as it<br />
considered that monitoring was a reminder of the<br />
potentially hazardous nature of X-ray equipment, and also<br />
that the information produced from monitoring in the<br />
event of any exposure incident is likely to be valuable.<br />
1.27 Use of Samarium 153<br />
The <strong>Committee</strong> noted that Samarium 153 was now being<br />
used in some other States as an alternative to<br />
strontium 89. As guidelines had been developed for<br />
strontium 89 the <strong>Committee</strong> decided that there was a need<br />
12<br />
to review these guidelines to assess whether a new<br />
guideline was required or whether the strontium 89<br />
guideline could be modified to include appropriate<br />
reference to samarium 153. The <strong>Committee</strong> requested<br />
that the strontium 89 working party be reconvened to<br />
develop a draft guideline for consideration. Membership<br />
of the working party would be:<br />
Dr M Kelly (RAC, ANZAPNM)<br />
Mr B van Every (ANZSNM)<br />
Dr J Heggie (RAC, ACPSEM)<br />
Dr A Wirth (RAC, RACR- Oncology)<br />
Mr A Melbourne (RSU)<br />
Ms I Cardillo (RSU)<br />
A letter was also received from Dr A Scott, Chairman,<br />
Therapy Sub-committee of RACP indicating that his subcommittee<br />
was also examining this issue. The working<br />
party will liaise with the therapy sub-committee.<br />
1.28 Need for Teleradiology Guideline<br />
The <strong>Committee</strong> received a draft document on the<br />
guidelines for regulatory control of teleradiology for<br />
comment. The document had been presented to the<br />
national <strong>Radiation</strong> Health <strong>Committee</strong> for consideration.<br />
That <strong>Committee</strong> had made no decision on proceeding with<br />
the draft, however the <strong>au</strong>thor was interested in State<br />
feedback on the usefulness of the approach taken. The<br />
<strong>Committee</strong> supported the need for a uniform approach<br />
around Australia on this issue and supported the concept<br />
that a document on teleradiology would be useful.<br />
1.29 Use of Iodine 131 for Treatment of<br />
Hyperthyroidism in Cats<br />
A request was received from two veterinary centres for<br />
approval to use iodine 131 to treat hyperthyroidism in<br />
cats. The <strong>Committee</strong> advised that the veterinarians would<br />
need to undertake a short course in radiation safety related<br />
to use of iodine 131 for this purpose. <strong>Radiation</strong> Safety<br />
Unit held discussions with Mr Ray de Groot, Health<br />
Physics consultant, as a result of which a suitable training<br />
course was developed involving a reading course and<br />
examination, practical experience in a nuclear medicine<br />
department and participation in administrations of iodine<br />
131 to cats. The veterinarians undertook the training and<br />
subsequently had licences approved.<br />
1.30 National Radioactive Waste<br />
Repository<br />
The <strong>Committee</strong> was provided with the information kit<br />
prepared by the Department of Primary Industry and<br />
Energy on the proposed development of a national<br />
repository for radioactive waste. The information kit<br />
offered opportunity for comment. The <strong>Committee</strong><br />
responded strongly supporting the development of a<br />
national radioactive waste repository, commending DPIE<br />
on the thoroughness of the consultative process and<br />
quality and scope of information provided, supported the<br />
choice of the Billa Kalina region in South Australia for<br />
detailed study. The <strong>Committee</strong> asked for ad<strong>vic</strong>e on the
intended total capacity of the facility and noted two areas<br />
in the discussion document that will require careful<br />
attention. These were a comprehensive and effective<br />
consultation program with the people in the region, and a<br />
carefully controlled transportation program for the initial<br />
collection of existing waste and loading of the repository.<br />
1.31 CT Scanner Registration Conditions <br />
Swan Hill Hospital<br />
Dr Jarvis of Bendigo Radiology wrote requesting a<br />
variation of conditions of registration of the CT scanner at<br />
Swan Hill hospital to allow the scanner to be used for<br />
routine procedures without the radiologist being present.<br />
The CT code allows scanners to be operated without a<br />
radiologist present only in emergency situations where the<br />
radiologist is on the way or is in contact via an<br />
appropriate teleradiology system. The <strong>Committee</strong><br />
considered the request but decided that it not be approved<br />
as the code requires a radiologist to be present for<br />
procedures not of an emergency nature.<br />
1.32 Use of Image Intensifiers by<br />
Unlicensed Persons - Royal<br />
Melbourne Hospital<br />
Two cases of use of image intensifier equipment in<br />
operating theatres at the Royal Melbourne Hospital were<br />
reported to the <strong>Committee</strong> during the year. The first<br />
related to Cardiology and the Second to Orthopaedic<br />
surgery. In both cases the communication system used to<br />
arrange for on-call radiographers to attend had failed and<br />
decisions had been taken to commence the procedures<br />
with no licensed person present. In the initial case the<br />
<strong>Committee</strong> recommended writing to the Director of<br />
Cardiology. The <strong>Committee</strong> was satisfied with the action<br />
taken in response. Subsequent to the second case the<br />
<strong>Committee</strong> recommended that the CEO of the hospital be<br />
advised of the hospital’s responsibility to ensure that<br />
equipment is only operated by licensed people and that<br />
any future instances of unlicensed persons operating<br />
equipment may lead to prosecution.<br />
1.33 Department Store for Obsolete<br />
Radioactive Materials<br />
The <strong>Radiation</strong> Safety Unit provided a report on the status<br />
and history of the store for obsolete radioactive materials,<br />
which is located in a basement area of Peter MacCallum<br />
Cancer Institute. The type of material in storage is<br />
predominantly sealed sources formerly used in medical,<br />
industrial and consumer applications. These include<br />
radium needles, strontium applicators, iridium wire,<br />
industrial level g<strong>au</strong>ges and thickness g<strong>au</strong>ges, and smoke<br />
detectors. Collection of material has been minimised by a<br />
policy that sources be returned to the supplier at the end<br />
of their useful life wherever possible. The <strong>Committee</strong> was<br />
satisfied that arrangements for storage of the material<br />
were safe and appropriate. However, the <strong>Committee</strong><br />
proposed that a system of review of the store by an<br />
external independent expert be conducted at intervals.<br />
The report of the consultant should be presented to enable<br />
13<br />
the <strong>Committee</strong> to continue to monitor the store’s<br />
operation.<br />
1.34 Course on Radiography for General<br />
Practitioners<br />
Professor Tress reported that the Radiography for General<br />
Practitioners course which had previously been run by the<br />
University of Melbourne Continuing Medical Education<br />
Unit was to be run this year by the University Radiology<br />
Department. Future operation of the course would be<br />
subject to the deliberations of the working party on<br />
general practice radiography.<br />
1.35 Application for Operator Licence, Ms<br />
Paton, Upper Murray Health &<br />
Community Ser<strong>vic</strong>es<br />
A request was received from the Chief Nursing Executive<br />
Officer of Upper Murray Health & Community Ser<strong>vic</strong>es<br />
to licence a nurse, Ms Helen Paton to operate X-ray<br />
equipment at the hospital. The request arose bec<strong>au</strong>se all<br />
the general practitioners licensed at Corryong had left the<br />
town and the locum general practitioners did not hold<br />
licences and did not wish to take X-rays. The request was<br />
for simple X-rays only, with more complex cases being<br />
referred to Albury/Wodonga. The nurse had previously<br />
held a licence in Western Australia for simple procedures.<br />
The hospital advised they expected that it could take<br />
several months before permanent general practitioners<br />
could be appointed. The <strong>Committee</strong> recommended that a<br />
restricted licence be granted for a period of one year, that<br />
a refresher training course be undertaken in<br />
Albury/Wodonga. It would be expected that the licence<br />
not be required when replacement general practitioners<br />
are appointed.<br />
1.36 Request for Examination in<br />
Cambodian Language<br />
A request was received from Nissan Casting Plant for an<br />
employee required to pass an examination to obtain an<br />
industrial radiography licence to have that examination<br />
conducted in Cambodian as his command of English was<br />
poor. The <strong>Committee</strong> was concerned that some basic<br />
English was required for reading warning signs, labels etc<br />
and that it was not appropriate to set the examination in<br />
Cambodian. It was recommended that the company assist<br />
the employee to attain improved skills in English to assist<br />
in passing the examination.<br />
1.37 Application to operate Image<br />
Intensifier, Mr W Straffon, Urologist,<br />
Maryvale Private Hospital<br />
The <strong>Committee</strong> considered an application from Mr WGE<br />
Straffon, Urologist to operate an image intensifier at<br />
Maryvale Private Hospital in conjunction with a private<br />
lithotripsy ser<strong>vic</strong>e. The ser<strong>vic</strong>e was not considered to be<br />
an emergency ser<strong>vic</strong>e and consequently procedures could
e scheduled at a time and place where radiography<br />
ser<strong>vic</strong>es were provided. The <strong>Committee</strong> therefore<br />
recommended that the application be refused.<br />
1.38 Exemption from Licence to Store<br />
X-ray Equipment<br />
The <strong>Radiation</strong> Safety Unit requested ad<strong>vic</strong>e on the<br />
requirement that a person must hold a licence to store an<br />
X-ray unit that is not in use. The current computer system<br />
enables monitoring of units in storage and follow up<br />
letters to be easily generated. The addition of a licence in<br />
those few cases where this would be required purely for a<br />
unit in storage does not seem to add any benefit. The<br />
<strong>Radiation</strong> Safety Unit proposed that the requirement to<br />
hold a licence for these circumstances be abolished by<br />
exemption. The committee recommended that the<br />
proposal be approved and that an appropriate exemption<br />
condition requiring notification of sale, relocation or<br />
intention to use be implemented.<br />
1.39 Application of CT Code to<br />
Radiotherapy Treatment Planning CT<br />
Scanners<br />
The <strong>Radiation</strong> Safety Unit requested ad<strong>vic</strong>e as to whether<br />
the CT Code of Practice should be applied to CT scanners<br />
used for radiotherapy treatment planning. The <strong>Committee</strong><br />
advised that the Code would need to be applied<br />
particularly in relation to image quality and radiation<br />
safety considerations for 10 year old scanners. Any issues<br />
raised about other cl<strong>au</strong>ses of the Code would be<br />
considered on the basis of further information.<br />
1.40 Request for Exemption from<br />
Licensing Examination - Mr F Bove<br />
Mr F Bove, an operator of nuclear moisture/density<br />
meters requested exemption from the requirement to pass<br />
the Department’s radiation safety examination, which is a<br />
pre-requisite to obtain a licence. The <strong>Committee</strong><br />
considered Mr Bove’s arguments but decided that he<br />
should not be exempted from passing the examination.<br />
1.41 Approval for Rapiscan Secure 1000<br />
The <strong>Committee</strong> received a request from A&I Distributors<br />
Pty Ltd for approval of a Rapiscan Secure 1000 for use at<br />
a Victorian prison. The de<strong>vic</strong>e uses backscatter X-ray<br />
technology to scan people for concealed materials. The<br />
dose is extremely low (about 0.03 microsieverts per scan).<br />
Scanning would not be compulsory but would be offered<br />
as an alternative to a body search. The <strong>Committee</strong><br />
requested further information from A&I Distributors.<br />
After consideration of the additional material related to<br />
operator exposure, information to be provided to persons<br />
before they were scanned, and training provided to<br />
operators the <strong>Committee</strong> recommended that the use of the<br />
equipment be approved subject to provision of<br />
satisfactory information to obtain informed consent being<br />
provided, that the equipment includes a suitable radiation<br />
14<br />
warning label, and that operators are monitored for a<br />
period of at least 6 months to confirm that doses are low.<br />
1.42 Review of Health Act 1958<br />
The <strong>Committee</strong> met with Mr Tim Lunn, Legislation<br />
Review Team, who sought the <strong>Committee</strong>’s views on<br />
aspects of the Health Act related to radiation safety. He<br />
advised that a review has been commissioned in<br />
accordance with the Victorian Government’s Timetable<br />
for the Review and Reform of Legislation that Restricts<br />
Competition. In addition, the Public Health &<br />
Development Division has decided to undertake a broader<br />
review of the Act to determine if there are any other ways<br />
in which its operations might be improved.<br />
1.43 CT Scanner Installation, Gippsland<br />
Diagnostic Ser<strong>vic</strong>es<br />
A request was received to approve the installation of a CT<br />
scanner at Gippsland Diagnostic Ser<strong>vic</strong>es, Morwell. The<br />
scanner was to be installed in a building which was<br />
separated from the remainder of the practice by a laneway<br />
which led to the practice car park. The practice included<br />
bone densitometry, ultrasound, general radiography,<br />
fluoroscopy and mammography. It therefore met the<br />
requirements of the CT Code regarding modalities needed<br />
to be classified as a comprehensive practice. A<br />
radiologist was present on site at all times. Clarification<br />
was required as to whether having the CT scanner in a<br />
separate building would still be deemed to meet the<br />
requirements of the Code. The <strong>Committee</strong> considered that<br />
the practice met the requirements as a comprehensive<br />
practice and recommended that the registration be<br />
approved.<br />
1.44 <strong>Radiation</strong>-Wise Personal Monitoring<br />
Ser<strong>vic</strong>e<br />
The <strong>Committee</strong> reviewed a request from <strong>Radiation</strong>-Wise<br />
for approval under regulation 53 of the Health (<strong>Radiation</strong><br />
Safety) Regulations 1994 to operate a personal radiation<br />
monitoring ser<strong>vic</strong>e. <strong>Radiation</strong>-Wise use the Land<strong>au</strong>er<br />
laboratory in the USA to undertake the dosimetry. The<br />
ser<strong>vic</strong>e had approvals and accreditations from US<br />
DOELAP, NVLAP, AECB (Canada) H&SE (UK) and<br />
WA Radiological Council. The <strong>Committee</strong> recommended<br />
that the ser<strong>vic</strong>e be recognised under regulation 53.<br />
1.45 Other Matters Considered<br />
• The <strong>Committee</strong> discussed a UK article about doses to<br />
family members after iodine 131 treatment. The<br />
article highlighted the fact that in some countries<br />
patient discharge limits were now based on dose<br />
considerations rather than activity remaining in the<br />
patient’s body. It was noted that the Australian<br />
guidelines on discharge of patients from hospital after<br />
treatment with radioactive material were currently<br />
being reviewed.<br />
• The <strong>Committee</strong> approved the amendment of an<br />
operator licence for a research nutritionist to operate a
one mineral densitometer at University of Melbourne.<br />
Approval had previously been granted to operate at<br />
Deakin Institute of Nutrition.<br />
• The <strong>Committee</strong> was advised of the outcome of a<br />
previous request for ad<strong>vic</strong>e from the South Australian<br />
Health Commission regarding endocrinologists<br />
proposing to set up an X-ray facility and employ<br />
radiographers to take spinal X-rays. The SAHC<br />
recommended that all films be read by a radiologist.<br />
This was consistent with the ad<strong>vic</strong>e provided by the<br />
<strong>Committee</strong>.<br />
• The <strong>Committee</strong> was asked by Assoc Professor Seeman<br />
of Austin & Repatriation Medical Centre to give<br />
general agreement to the hiring of either an MIT,<br />
NMT or science graduate to operate a bone mineral<br />
densitometer for scanning all patients, be they<br />
privately referred, research or clinical drug trial<br />
patients. The <strong>Committee</strong> responded that it would<br />
consider applications on their individual merits. The<br />
actual issuing of an operator licence would depend on<br />
the qualifications and experience of the person<br />
applying. Such a person ideally would be trained in<br />
radiation technology. The <strong>Committee</strong> also advised<br />
that licences to scan clinical patients have only been<br />
issued to medical radiation technologists and that any<br />
variation to this would require specific consideration.<br />
• The <strong>Committee</strong> noted an article by Jaworowski on<br />
Beneficial Effects of <strong>Radiation</strong> and Regulatory<br />
Control. The article discusses evidence for a radiation<br />
hormesis effect at low doses and the implications for<br />
radiation protection regulations. The <strong>Committee</strong> will<br />
continue to review literature in this area.<br />
• The <strong>Committee</strong> received information on a proposal to<br />
operate a teleradiology ser<strong>vic</strong>e from Hong Kong. It<br />
was recommended that the proponent discuss the<br />
matter with the Medical Board and Medicare as the<br />
issues raised were outside the area of radiation safety.<br />
• The <strong>Committee</strong> noted and congratulated one of its<br />
members, Dr Graham Rouch on his receipt of the<br />
Public Ser<strong>vic</strong>e Medal for ser<strong>vic</strong>es to the Public Health<br />
field in the State of Victoria.<br />
• The <strong>Committee</strong> noted information provided on a Xiscan<br />
Mini C-arm Image Intensifier which is a low dose<br />
machine designed specifically for imaging of the<br />
extremities. The <strong>Committee</strong> requested further<br />
15<br />
information on a request from Mr Chris Haw,<br />
Orthopaedic Surgeon , to be licensed to operate a<br />
similar FluoroScan mini C-arm image intensifier in his<br />
private rooms.<br />
• The <strong>Committee</strong> noted the <strong>Radiation</strong> Safety Unit’s<br />
involvement in a Dental Board hearing into the<br />
practice of Dr M White. Dr White’s registration with<br />
the Dental Board was cancelled. The <strong>Committee</strong><br />
recommended that the <strong>Radiation</strong> Safety Unit seek<br />
ad<strong>vic</strong>e on appropriate action concerning Dr White’s<br />
operator licence and the unregistered X-ray unit he<br />
owns.<br />
• The <strong>Committee</strong> considered an application from Ms<br />
Alana Sarah to operate a bone mineral densitometer as<br />
part of research studies being undertaken at Geelong<br />
Hospital. She completed VCE last year and has no<br />
tertiary qualification. The <strong>Committee</strong> noted that<br />
licences had only been issued in the past to radiation<br />
technologists or to science graduates involved with<br />
research studies. The <strong>Committee</strong> recommended that<br />
no exception could be made in this case and that the<br />
application should be refused.<br />
• The <strong>Committee</strong> noted the recommendations of the<br />
Review of Radiotherapy Ser<strong>vic</strong>es, which were<br />
provided for information.<br />
• The <strong>Committee</strong> noted ad<strong>vic</strong>e that the Trans-Tasman<br />
Mutual Recognition Arrangement was to start on 1<br />
May 1998 and that its requirements would need to be<br />
taken into account in consideration of future licence<br />
applications.<br />
• The <strong>Committee</strong> recommended against extending<br />
licences issued to science graduates to operate bone<br />
mineral densitometers for research purposes to allow<br />
their operation for clinical purposes. The <strong>Committee</strong><br />
requested that justification for such a change would be<br />
required and that the matter would need to be<br />
discussed with the Medical <strong>Radiation</strong> Technologists<br />
Board.<br />
• The <strong>Committee</strong> also recommended that a request for<br />
exemption from personal monitoring of theatre staff at<br />
Coonara Private Hospital be reviewed in 12 months,<br />
although those staff who do not remain in the room<br />
during fluoroscopy need not be monitored.
16<br />
2. RADIOGRAPHY IN GENERAL PRACTICE<br />
2.1 Introduction<br />
During 1996 the <strong>Committee</strong> established a sub-committee<br />
on general practice radiography. This sub-committee had<br />
representation of RACR, RACGP, AIR, AMA, the<br />
<strong>Committee</strong> and the <strong>Radiation</strong> Safety Unit. The subcommittee<br />
identified issues on training of general<br />
practitioners for radiography, and as a result of this the<br />
<strong>Committee</strong> formed a working party to examine training<br />
issues and maintain an ongoing forum for communication.<br />
2.2 Membership<br />
Members of the working party were nominated by the<br />
RACGP, AMA, RACR, along with representatives of the<br />
<strong>Committee</strong> and the Department. The RACGP and RACR<br />
were also asked to nominate an additional person to<br />
represent rural general practitioners and radiologists<br />
respectively. The members were:<br />
(Chair) Professor Brian Tress RAC<br />
Dr Michael Martin RACR<br />
Dr Graeme Buirski RACR<br />
(rural)<br />
Dr Jack Lipp RACGP<br />
Dr Jon Barrell RACGP<br />
(rural)<br />
Dr Peter Graham AMA<br />
Mr John Lavan AIR<br />
Dr Graham Rouch RAC<br />
Mr Alan Melbourne RSU<br />
2.3 Issues Discussed by Working Party<br />
The working party held one meeting in November 1997<br />
with Dr Barrell and Dr Buirski present via<br />
videoconferencing from Ballarat, and Dr Graham via<br />
teleconferencing from Cohuna. Dr Martin was unable to<br />
attend. Discussion centred around the current University<br />
of Melbourne course, and in particular, the objectives of<br />
the course, syllabus of the course, and options for<br />
different ways to present the course to make it more<br />
accessible to general practitioners. There was also<br />
discussion on options for the extended course which<br />
would provide additional training for rural general<br />
practitioners. The particular issues related to the duration<br />
and cost of the course and whether it could be presented at<br />
regional locations in full or in part so that rural general<br />
practitioners would have better chance to attend.<br />
2.4 Summary of Working Party<br />
Discussions<br />
A summary of the meeting was presented to the<br />
<strong>Committee</strong>. The working party agreed that a position<br />
paper be prepared examining options for presentation of<br />
the course. It was intended that this paper would<br />
ultimately be circulated to the Colleges to obtain their<br />
agreement prior to adoption.
3. NON-IONIZING RADIATION<br />
3.1 Papers Considered in the Past 12<br />
Months Related to Biological Effects<br />
from Exposure to Power Frequency<br />
Electromagnetic Fields<br />
The attention of the <strong>Committee</strong> was directed to the<br />
question of possible <strong>health</strong> effects associated with<br />
exposure to power frequency electromagnetic fields.<br />
The Meta-Analysis Project <strong>Advisory</strong> Group in its report<br />
submitted to the Minister for Health in December 1988<br />
recommended that the Minister for Health commission<br />
and publish each year for at least the next five years a<br />
report summarising studies in the literature within the<br />
previous year on the effects on human <strong>health</strong> of exposure<br />
to non-ionizing radiation at or near the powerline<br />
frequency.<br />
In addition, the report of the Panel on Electromagnetic<br />
Figure 2. High Tension Powerlines<br />
Fields and Health, commissioned by the Minister for<br />
Health, was released by the Minister in September 1992.<br />
One recommendation in the Minister's response to the<br />
report was that the newly appointed <strong>Radiation</strong> <strong>Advisory</strong><br />
<strong>Committee</strong> continue to monitor, and produce regular<br />
updates, on the medical and scientific literature on<br />
possible <strong>health</strong> effects from power frequency<br />
electromagnetic fields.<br />
A list of papers considered by the <strong>Committee</strong> in the past<br />
12 months is presented in Appendix VII.<br />
Cell Studies<br />
Efforts continue to identify short-term changes in cellular<br />
metabolism that might indicate a link to long-term adverse<br />
effects. Dibirdik et al. present evidence that exposure of<br />
lymphoma B-cells to 0.1 mT magnetic fields leads to<br />
activation of a specific type of phospholipase C. This is<br />
interpreted as field stimulation of a particular gene.<br />
However, similarly designed experiments performed by<br />
other groups in the past have yielded no effect. Of interest<br />
(in relation to the melatonin hypothesis) is the finding of<br />
17<br />
Rosen, Barber & Lyle of a 46% average reduction in the<br />
production of this hormone by isolated pineal cells<br />
exposed to fields of 0.05 mT magnitude. The melatonin<br />
hypothesis is that reductions in melatonin levels<br />
previously reported in in-vivo experiments are linked to<br />
increased susceptibility to cancer, although this link has<br />
not been substantiated.<br />
Animal Studies<br />
Following the publication of the Australian study of the<br />
exposure of transgenic mice to mobile phone radiation,<br />
the companion study, using power frequency (50 Hz)<br />
magnetic fields, was published during the year. In contrast<br />
to the former study, the latter (Harris et al.) showed no<br />
statistical difference in lymphoma rate between exposed<br />
and sham-exposed groups, although there was a<br />
significant difference in transgene-related renal disease<br />
between the 1 mT continuous exposure group and control,<br />
but not between the 1 mT pulsed exposure group and<br />
control.<br />
In a Swedish study (Ekstrom, Mild & Holmberg,) on rats<br />
in which mammary tumours were induced by a chemical<br />
agent dimethylbenz[a]anthracene (DMBA), exposure to<br />
0.25 and 0.5 mT 50 Hz continuous magnetic fields, no<br />
significant differences were obtained either for the number<br />
of animals with tumours or the number of tumours per<br />
animal.<br />
In a Finnish study (Kumlin, Kosma et al.) skin cancers<br />
were induced in mice by exposure to ultraviolet radiation<br />
with or without 50 Hz 0.1 mT magnetic field. Both normal<br />
mice and mice genetically engineered to overproduce the<br />
enzyme ornithine decarboxylase were studied, the latter<br />
showing a statistically significant increase in the rate of<br />
development of cysts. On the other hand, both transgenic<br />
and non-transgenic mice showed a significant increase in<br />
the number of animals with tumours with magnetic field<br />
exposure.<br />
On the other hand neither Mandeville, Franco et al. nor<br />
Yasui, Kikuchi et al. found any significant changes in a<br />
number of cancer-related endpoints in studies of groups of<br />
rats exposed for up to 2 years at a variety of field levels<br />
up to 5 mT.<br />
Two studies have examined effects of power frequency<br />
magnetic fields on spatial learning capabilities of<br />
experimental animals, both finding reductions in<br />
performance (Lai, Carino & Ushijima; Sienkiewicz,<br />
Haylock & S<strong>au</strong>nders; 1 mT and 0.75 mT respectively).<br />
Zecca, Mantegazza et al. report some changes in opioid<br />
receptors and pineal responses in brains of rats exposed to<br />
EMF for 8 months, with some inconsistency. Reiter, Tan<br />
et al. have found reductions in serum melatonin in rats<br />
exposed to effectively a 1 Hz square wave, but these<br />
reductions were also inconsistent. In human volunteers<br />
Wood, Armstrong et al. showed evidence for a delay in<br />
melatonin onset time of about 30 minutes following<br />
exposure to 0.028 mT fields.
Sastre, Cook et al. studied heart rate variability in human<br />
volunteers exposed overnight to a 0.028 mT magnetic<br />
field. Spectral analysis of beat-to-beat variation showed a<br />
significant drop in the ratio of low frequency to high<br />
frequency components during exposure, changes similar<br />
to those observed in a variety of cardiovascular diseases.<br />
Epidemiology<br />
The Non-Ionizing <strong>Radiation</strong> Sub-<strong>Committee</strong> of the RAC<br />
(since disbanded) reviewed eight major epidemiological<br />
studies in May 1993. A copy of this review is included as<br />
Appendix IV in the annual report of the RAC for the year<br />
ending September 1993. These studies were better<br />
designed and coordinated than previous studies and<br />
sought to redress the weaknesses inherent in them.<br />
The RAC has subsequently reviewed the important<br />
epidemiological studies over the past year and a copy of<br />
the results are included as Appendix VIII of this report.<br />
Once again these studies have been well designed and<br />
coordinated. However, they still suffer from the ongoing<br />
problems of possible confounding and bias, control<br />
selection, and the fact that the exposure assessment, whilst<br />
improved, is still imperfect. It is important that these<br />
problems are thoroughly addressed, particularly exposure<br />
assessment, before epidemiologic research in this area will<br />
be able to produce more meaningful results.<br />
In summary, one of the continuing problems with regard<br />
to epidemiologic research in this area is that, bec<strong>au</strong>se of<br />
the generally low odds ratios obtained (of the order of 2),<br />
it is quite possible that the results obtained are due to the<br />
problems mentioned above. Thus it is still not possible to<br />
conclude that exposure to power frequency electric and<br />
magnetic fields contributes to chronic <strong>health</strong> effects such<br />
as cancer.<br />
Dosimetry<br />
International research is continuing to attempt to quantify<br />
trends of domestic and occupational exposure to power<br />
frequency magnetic fields. This information can be used<br />
in epidemiological studies of possible <strong>health</strong> effects<br />
associated with the magnetic fields. Debate has continued<br />
over what would be the most appropriate type of magnetic<br />
field measurement to make as an indicator of putative risk<br />
in relation to cancer incidence.<br />
International research is continuing to attempt to quantify<br />
trends of domestic and occupational exposure to power<br />
frequency magnetic fields.<br />
This information can be used in epidemiological studies<br />
of possible <strong>health</strong> effects associated with the magnetic<br />
fields. Debate has continued over what would be the most<br />
appropriate type of magnetic field measurement to make<br />
as an indicator of putative risk in relation to cancer<br />
incidence. Wenzl, for example, has measured the<br />
magnetic field exposure of rail maintenance workers in<br />
Philadelphia, Pennsylvania, where the trains are operated<br />
by 25 Hz electric power. He found that the workers were<br />
exposed to magnetic fields at a number of different<br />
18<br />
frequencies, illustrating the difficulty regarding the choice<br />
of exposure metric. Nevertheless he concludes that<br />
magnetic field exposures for these rail maintenance<br />
workers are somewhat elevated compared with those of<br />
other workers.<br />
Skotte and Hjolland found that welders and other metal<br />
workers are also exposed to high magnetic fields, with the<br />
average exposure for manual metal arc welding being 21.2<br />
µT and for MIG/MAG welding being 2.3 µT. This may<br />
be compared with the average exposure of Victorian<br />
office workers of about 0.16 µT, as obtained from the<br />
survey of office workers carried out by the <strong>Radiation</strong><br />
Safety Unit and reported on in last year's <strong>Annual</strong> <strong>Report</strong>.<br />
Reviews and Editorials<br />
In 1992, the US Congress mandated a Program in the<br />
Energy Policy Act to both sponsor high-quality research<br />
into <strong>health</strong> effects of power frequency magnetic fields and<br />
to collect and evaluate information for a final report. This<br />
report, from the Director of the National Institute of<br />
Environmental Health Sciences, is due to be submitted to<br />
Congress in late 1998. As a prelude to this a lengthy and<br />
wide-ranging process drawing together world-wide<br />
scientific opinion and comment from the general public is<br />
nearing completion. Recently a NIEHS multi-disciplinary<br />
Working Group of 29 scientists met to consider the<br />
outcomes of earlier Review Symposia and to produce a<br />
report (Portier & Wolfe). This group determined its<br />
position on a number of issues by a simple voting<br />
procedure. The most controversial outcome was a vote of<br />
19 to 9 (with one abstention) that EMF should be<br />
considered a ‘possible human carcinogen’. This was<br />
based on considerations of epidemiological evidence for<br />
childhood leukaemia and adult chronic lymphocytic<br />
leukaemia from occupational exposure. The group found<br />
inadequate evidence for other diseases or other cancers.<br />
On the other hand, the majority (19 members) voted in<br />
favour of the statement that 'there is inadequate evidence<br />
from experimental animals for carcinogenicity' and 8 in<br />
favour of the stronger 'lack' of carcinogenicity.<br />
International Guidelines<br />
The International Commission on Non-Ionizing <strong>Radiation</strong><br />
Protection (ICNIRP) published guidelines for limiting<br />
exposure to time-varying electric, magnetic and<br />
electromagnetic fields (up to 300 GHz) in April 1998.<br />
The reference levels for occupational exposure in the<br />
above guidelines are virtually the same as the maximum<br />
exposure levels in the Interim Australian/New Zealand<br />
Standard AS/NZS 2772.1 (Int): 1998 up to 400 MHz. For<br />
frequencies higher than 400 MHz, however, AS/NZS<br />
2772.1 is more stringent in that, in the ICNIRP guidelines,<br />
the reference level increases from 400 to 2000 MHz,<br />
beyond which it is constant up to 300 GHz: 137 V/m for<br />
the E field and 0.36 A/m for the H field as compared to 61<br />
V/m and 0.16 A/m in AS/NZS 2772.1.
The same holds for non-occupational exposure. For the<br />
range 2000 MHz to 300 GHz in this case the limits are 61<br />
V/m for the E field and 0.16 A/m for the H field in the<br />
ICNIRP guidelines as compared to 27.5 V/m and 0.073<br />
A/m in AS/NZS 2772.1.<br />
It should be noted that the ICNIRP guidelines apply down<br />
to zero Hz. The reference level at 50 Hz is 500 T for the<br />
B field and 10 kV/m for the E field for occupational<br />
exposure and 100 T and 5 kV/m for non-occupational<br />
exposure, the same as in the ICNIRP Interim guidelines<br />
on limits of exposure to 50/60 Hz electric and magnetic<br />
fields.<br />
Other<br />
Wartenberg; Stevens; and Neutra criticised the study of<br />
Linet et al (N Engl J Med 1997; 337: 1- 7). In response to<br />
Wartenberg, Linet et al stated that they did not dismiss the<br />
odds ratio with the cut off point for low/high exposure of<br />
0.3 µT but rather they tended to discount the increase in<br />
risk bec<strong>au</strong>se of the post hoc nature of the analysis, the<br />
inconsistent dose response pattern (markedly increased<br />
risk level at a level of 0.4 to 0.499 µT but no increased<br />
risk level at a level of 0.5µT or higher), the absence of a<br />
significant trend, and the small number of exposed<br />
children. Again in response to Wartenberg they<br />
responded that, although socioeconomic status (SES) bias<br />
would tend to inflate their risk estimates, they did adjust<br />
for SES.<br />
Responding to Stevens they stated that none of the<br />
matched analyses for certain exposure levels were<br />
highlighted in their paper bec<strong>au</strong>se they did not show a<br />
significantly increased risk.<br />
Neutra's assertion of the similarity between the study of<br />
Linet et al and that of Feychting and Ahlbom (Am J<br />
Epidemiol 1993;138: 467-481) drew the comment from<br />
Linet et al that parallels drawn between the Swedish<br />
estimates (of magnetic field exposure) and our<br />
measurements are of uncertain relevance.<br />
3.2 Papers Considered in the Past 12<br />
Months Related to Biological Effects<br />
from Exposure to Radiofrequency<br />
<strong>Radiation</strong><br />
Possible <strong>health</strong> effects of emissions from mobile phones<br />
has continued to dominate research into biological effects<br />
of radiofrequency radiation (RFR). The Federal Health &<br />
Family Ser<strong>vic</strong>es Department announced three<br />
Electromagnetic Energy Research Grants totalling<br />
$215,000 for research projects on mobile phone safety,<br />
one an epidemiological study on tumours of the head, the<br />
second, effects on DNA and the third on users' memory,<br />
concentration or problem-solving abilities.<br />
Earlier studies had suggested that non-thermal levels of<br />
RFR at microwave oven frequency could induce damage<br />
to DNA. In a replication study published during the year,<br />
19<br />
Malyapa, Ahern et al. were unable to demonstrate any<br />
significant damage to DNA either with this form of RFR<br />
or that associated with mobile phone emissions (see<br />
second paper by same <strong>au</strong>thors). In these studies the<br />
sensitivity of the assay was estimated by comparison with<br />
DNA damage from low-level ionizing radiation.<br />
In two related studies (French, Donnellan & McKenzie;<br />
and Donnellan, McKenzie & French) cultured cells were<br />
exposed to unmodulated 835 MHz. The first describes<br />
significant flattening of shape at both 2W and 10W power<br />
levels in astrocytes, the second. The second, using RBL<br />
2H3 cells, shows an appearance of actin in 'ruffles' in<br />
exposed cells, a greater secretion (of β-hexosaminidase)<br />
and a slower rate of proliferation. It has been suggested<br />
that these are thermal effects: cells are not temperature<br />
controlled whilst in exposure system (which is a 1 m cube<br />
aluminium box) and exposed cells are 0.8°C higher than<br />
controls.<br />
In human studies, Mann, Wagner et al. showed that<br />
mobile phone emissions had no effect on neuroendocrine<br />
parameters such as melatonin and growth hormone, but a<br />
slight transient elevation in the hormone cortisol. In a<br />
related report, Wagner, Röschke et al. were unable to<br />
replicate an earlier finding by the same group of<br />
suppression of Rapid Eye Movement (REM) sleep.<br />
Similarly, de Seze, Fabbro-Peray & Miro showed no<br />
changes in pituitary hormone secretion following<br />
exposure to mobile phone emissions 2 hr/day for 1 month.<br />
Figure 3. Cellular mobile phone base station<br />
There was, however, a significant reduction in thyrotropin<br />
during the period of exposure, followed by a rebound in<br />
the weeks following cessation of exposure.<br />
In a letter to the editor of the Medical Journal of<br />
Australia, Davidson presented data which he interpreted<br />
as an increase in brain tumour incidence in the years<br />
following the introduction of analogue mobile phones in<br />
Australia, followed by a fall after digital phones were<br />
introduced. Others have pointed out an assumption of zero<br />
latent period between exposure and diagnosis of brain<br />
cancer is inappropriate. McKenzie, Yin & Morrell have<br />
re-analysed data on childhood leukaemia in relation to<br />
proximity to TV broadcast towers in Sydney and have<br />
concluded that since different locations recording similar<br />
RF radiation exposures have leukaemia incidences<br />
differing by almost three times it is unlikely that RFR is a<br />
c<strong>au</strong>sative factor. In fact, if data from one of the 16 local
<strong>gov</strong>ernment areas is excluded the association of<br />
leukaemia incidence with RFR exposure disappears.<br />
The question of mobile phone power absorption in the<br />
heads of children has been studied by Shönborn,<br />
Burkhardt & Kuster, who showed that if model phantoms<br />
based on realistic anatomy are used, there are no<br />
significant differences in absorption patterns between<br />
adults and children as young as 3 years.<br />
References for the papers considered are listed in<br />
Appendix IX.<br />
3.3 The <strong>Committee</strong>’s View on the Health<br />
Effects of Electromagnetic Fields<br />
The additional evidence concerning <strong>health</strong> effects of<br />
electromagnetic fields reviewed by the <strong>Committee</strong> during<br />
the past year has not been sufficiently compelling to alter<br />
the <strong>Committee</strong>’s position concerning the issue. This is<br />
that, overall, there is insufficient evidence to come to a<br />
firm conclusion regarding possible <strong>health</strong> effects from<br />
exposure to power frequency electric and magnetic fields.<br />
At this point in time (September 30) the final report for<br />
the US Congress from the National Institute of<br />
Environmental Health Sciences has not been finalised. It<br />
would therefore be premature to take the Working Group's<br />
categorisation of EMF as a 'possible carcinogen' as a<br />
definitive and conclusive statement, particularly in view of<br />
the insufficiency or lack of evidence from animal<br />
experiments. There are still at least two major<br />
epidemiological studies (from Canada & UK) to be<br />
published and these should form part of any summative<br />
evaluation.<br />
3.4 The <strong>Committee</strong>’s View on the Health<br />
Effects of Radiofrequency <strong>Radiation</strong><br />
The <strong>Committee</strong> considers that there is no substantive<br />
evidence to suggest that exposure to radiofrequency<br />
radiation can increase the risk of chronic <strong>health</strong> effects<br />
such as cancer. It has, however, noted the extent of public<br />
concern over the issue, particularly in view of the current<br />
controversy over mobile phones and base transmitters,<br />
and will continue to review the relevant research literature<br />
and, in particular, will monitor the progress of the projects<br />
supported by the Electromagnetic Energy Research<br />
Grants.<br />
3.5 Review of Physiotherapists Act<br />
The <strong>Committee</strong> met with Anne-Louise Carlton, Project<br />
Officer, Health Care Evaluation Section regarding the<br />
review of the Physiotherapists Act. Consideration was<br />
being given to whether there were radiation safety issues<br />
in the controls the Act currently places on the use of<br />
de<strong>vic</strong>es such as short wave diathermy machines,<br />
microwave diathermy machines, ultrasonic machines,<br />
laser machines, ultra violet machines and interferential<br />
20<br />
machines. After discussion on the various types of<br />
equipment it was agreed that if non-ionizing radiation<br />
equipment was to be regulated it would best be achieved<br />
under the radiation safety provisions of the Health Act<br />
rather than under the Physiotherapists Act. Ms Carlton<br />
would convey this in the review report.<br />
3.6 Review of Need for Non-ionizing<br />
<strong>Radiation</strong> Controls<br />
As a result of discussion on the Physiotherapists Act the<br />
<strong>Committee</strong> requested ad<strong>vic</strong>e on the controls in other<br />
States on non-ionizing radiation, and the available powers<br />
under the Health Act. It was noted that Western Australia<br />
and Tasmania currently have regulations <strong>gov</strong>erning nonionizing<br />
radiation, but other States do not. Some States,<br />
like Victoria have the power in their Act to regulate but<br />
have not done so. The <strong>Committee</strong> requested that the<br />
<strong>Radiation</strong> Safety Unit prepare a document reviewing the<br />
need for controls over non-ionizing radiation, including<br />
summarising the approaches taken elsewhere, whether<br />
there have been reports of injuries or accidents with nonionizing<br />
radiation equipment, what Standards for emission<br />
or exposure exist, and any relevant national or<br />
international recommendations.<br />
3.7 <strong>Radiation</strong> Health <strong>Committee</strong><br />
Statement on Hair Depilation Lasers<br />
The <strong>Committee</strong> noted that the national <strong>Radiation</strong> Health<br />
<strong>Committee</strong> had made a statement on the use of high<br />
powered lasers for hair depilation at its meeting on 9<br />
October 1997. The <strong>Radiation</strong> Health <strong>Committee</strong> said:<br />
A new technique using Class 4 lasers is currently being<br />
used in Australia for hair depilation. Given the growth in<br />
this application of medical lasers, the <strong>Radiation</strong> Health<br />
<strong>Committee</strong> agreed that policy guidance was required on<br />
this issue. To provide interim guidance, pending further<br />
consultation and review, the national <strong>Radiation</strong> Health<br />
<strong>Committee</strong> recommends that radiation control <strong>au</strong>thorities<br />
restrict the use of Class 4 lasers for hair depilation to<br />
medical practitioners who have received training in<br />
medical laser techniques and safety appropriate to this<br />
application.<br />
The <strong>Committee</strong> noted that there were no regulations on<br />
laser safety under the Health Act, however it supported<br />
the radiation Health <strong>Committee</strong> statement and<br />
recommended that it be taken into account in the review<br />
on non-ionizing radiation controls.<br />
The <strong>Committee</strong> also recommended that Thermolase<br />
Australia/NZ Pty Ltd, the supplier of a hair depilation<br />
laser on which the <strong>Committee</strong> had been provided<br />
information be advised of the <strong>Radiation</strong> Health<br />
<strong>Committee</strong> Statement.
3.8 Operation of Medical Lasers, Dr<br />
Garth Dicker<br />
A letter was received from Dr Garth Dicker expressing his<br />
concern about the use of Class 3 and 4 lasers in medicine.<br />
His concern had been raised by the recent introduction of<br />
new class 4 lasers for hair depilation. In particular, the<br />
issue of non-medical staff being employed to operate<br />
lasers in medical clinics concerned Dr Dicker. He<br />
21<br />
believed that a licensing system similar to that in Western<br />
Australia was necessary to ensure adequate control. The<br />
<strong>Committee</strong> noted Dr Dicker’s comments and requested<br />
that they be taken into account in the review of the need<br />
for non-ionizing radiation controls that is to be undertaken<br />
by the <strong>Radiation</strong> Safety Unit.
4. RADIATION INCIDENTS<br />
4.1 Damage to a Nuclear<br />
Moisture/Density G<strong>au</strong>ge<br />
The <strong>Committee</strong> was advised that the <strong>Radiation</strong> Safety<br />
Unit had responded to a report by AS James Pty Ltd on<br />
the afternoon of 1 June 1998 advising that a Troxler<br />
nuclear moisture/density g<strong>au</strong>ge had been run over by a<br />
truck. The incident occurred at roadworks north of<br />
Gisborne.<br />
<strong>Radiation</strong> Safety Unit officers attended the scene where<br />
the operator had roped off an area of a few metres around<br />
the g<strong>au</strong>ge. He advised us that a large earth moving truck<br />
(see figure 4) had reversed over the g<strong>au</strong>ge as he was about<br />
to carry out measurements with the g<strong>au</strong>ge. He looked up<br />
and saw the truck approaching and moved out of the way<br />
in order to avoid injury to himself.<br />
The Troxler g<strong>au</strong>ge involved, model 3440 has a 296 MBq<br />
(8 mCi) Cs-137 source on a moveable source rod which is<br />
lowered into the ground for density measurements and a<br />
1.48 GBq (40 mCi) Am-241/Be neutron source in the<br />
body of the g<strong>au</strong>ge for soil moisture content measurements.<br />
Figure 4. Truck which Ran Over G<strong>au</strong>ge<br />
At the time of the incident, the source rod was about<br />
23 cm in the ground. As a result of being run over by the<br />
truck the g<strong>au</strong>ge was badly crushed and the Cs-137 source<br />
rod was badly bent (see figure 5).<br />
The source rod was placed in a lead pot after noting that<br />
the source encapsulation appeared to be intact. The<br />
Am-241/Be source also appeared to be intact. The dose<br />
rate on the outside of the lead pot was about 300 Sv/h<br />
and the gamma dose rate on the surface of the Am-241/Be<br />
source was about 30 Sv/h.<br />
Earth was loosened to a depth exceeding that of the source<br />
rod’s penetration and monitored for possible<br />
contamination. Readings of the contamination monitor<br />
were not distinguishable from background. The wheel of<br />
the truck involved was also checked with a contamination<br />
monitor with the same result.<br />
22<br />
Figure 5. The Damaged G<strong>au</strong>ge<br />
The damaged g<strong>au</strong>ge was transported for interim storage in<br />
the Unit’s radioactive waste store. Prior to this a wipe test<br />
was carried out on both sources. The results of the wipe<br />
tests indicated that there was no leakage of radioactive<br />
material.<br />
AS James were to arrange for return of the sources to the<br />
supplier for disposal.<br />
The <strong>Committee</strong> was satisfied that no further action was<br />
required.<br />
4.2 Transport Incident - Wards<br />
Transport<br />
The <strong>Radiation</strong> Safety Unit responded to a pager message<br />
at 1:53am on 13 October 1997 from Fire Ser<strong>vic</strong>es at<br />
Melbourne Airport. Two packages of a consignment of<br />
23 packages signed over to Wards Transport had been<br />
found in a gutter in East St at the airport by a Qantas pilot.<br />
One of the packages was damaged and the external<br />
surface was wet. It appears that the package had blown<br />
off the landing bay and lodged between the van and the<br />
dock.<br />
The driver had been notified and had subsequently<br />
returned and collected the packages. Wards were<br />
Figure 6. Internal View of Package<br />
requested to isolate the van and to ensure that the driver<br />
remained until RSU staff arrived. The package contained
54.5 MBq of P-32. The package was examined and the<br />
inner containment was not damaged. There was no<br />
leakage of radioactive material. The package was<br />
subsequently repaired and forwarded to the consignee.<br />
The <strong>Committee</strong> was concerned that the driver had<br />
Figure 7. Damage to Exterior of Package<br />
returned and handled a damaged, wet package without<br />
being aware of whether there was leakage of radioactive<br />
material. Wards Transport were advised to ensure that<br />
drivers were instructed on appropriate action in the event<br />
of an incident.<br />
4.3 Industrial Radiography - Employee<br />
Enters Radiography Area - Tenix<br />
A report was received of an incident at Tenix Defence<br />
Systems Pty Ltd, wherein an engineer had entered a<br />
radiography area while industrial radiography was in<br />
progress. He had deliberately crossed a barrier rope,<br />
walked past a radiography warning sign and had been in<br />
the area for 30-90 seconds. The radiography site was<br />
within the hull structure of a ship under construction.<br />
When the operators became aware of the engineer’s<br />
presence the exposure was stopped. The incident was<br />
reported to the <strong>Radiation</strong> Safety Unit immediately. The<br />
dose to the engineer was estimated to be about 30 µSv.<br />
The <strong>Committee</strong> recommended that the management of<br />
Tenix Defence Systems be instructed to ensure that all<br />
staff take heed of safety signs and barriers and not enter<br />
radiography areas while work is in progress.<br />
4.4 Disposal of Gas Chromatograph<br />
Source - Centre for Forest Tree<br />
Technology<br />
The <strong>Committee</strong> received a report from the <strong>Radiation</strong><br />
Safety Unit that the Centre for Forest Tree Technology<br />
(part of the Department of Natural Resources and<br />
Environment) had advised that a gas chromatograph<br />
source of 296 MBq of nickel 63 had inadvertently been<br />
disposed of to municipal landfill when the obsolete<br />
equipment it was housed in failed to be sold by public<br />
tender. The incident had only been reported after a follow<br />
up by the <strong>Radiation</strong> Safety Unit on failure to renew a<br />
registration. The <strong>Committee</strong> noted that the there was<br />
negligible radiation danger from a gas chromatograph<br />
source but that the incident should have been reported to<br />
23<br />
the <strong>Radiation</strong> Safety Unit forthwith. The <strong>Committee</strong><br />
recommended that DNRE be reprimanded over the failure<br />
to account for the source and that all users of gas<br />
chromatographs be notified of the need to ensure that<br />
sources are not left in equipment for disposal.<br />
4.5 Industrial Radiography Incident <br />
Australian NDT Ser<strong>vic</strong>es P/L<br />
It was reported to the <strong>Committee</strong> that an incident occurred<br />
during industrial radiography procedures on Tuesday<br />
23 December 1997 at Fitzsimons Lane, Templestowe.<br />
The incident resulted in apparent radiation doses above<br />
the annual limit to the licensed operator, Mr Kevin<br />
Poulter, and Mr Bradley Mobbs, the radiography<br />
assistant. The incident was brought to the attention of the<br />
Department by management of Australian NDT Ser<strong>vic</strong>es<br />
P/L, their employer, on Tuesday 6 January 1998.<br />
During industrial radiography Mr Poulter was allegedly<br />
not using personal radiation monitoring de<strong>vic</strong>es, namely a<br />
thermoluminescent dosemeter (TLD) and a pocket beeper.<br />
He also allegedly did not use the radiation survey meter<br />
at the site to ensure that the radioactive source had been<br />
returned to the shielded position at the completion of each<br />
exposure. It would appear that the source was not<br />
correctly attached to the exposure cable at the<br />
commencement of procedures and as such was not<br />
returning to the shielded container at the end of each<br />
exposure. As Mr Poulter was allegedly not using the<br />
radiation survey meter correctly it was not discovered that<br />
the radioactive source had been out of the shielded<br />
container since the first exposure until an attempt was<br />
made to lock the container at the end of the day. As the<br />
container would not lock Mr Poulter used the survey<br />
Figure 8. Area where radiography took place<br />
meter and discovered that the source was not in the<br />
shielded container. He then retrieved the source by<br />
re-attaching it and returning it to the shielded container.<br />
The operators’ TLD badges were submitted for<br />
assessment and the radiation dose report form from the<br />
Australian <strong>Radiation</strong> Laboratory showed a dose of<br />
52600 Sv for Mr Mobbs and a dose of 330 Sv for<br />
Mr Poulter. Mr Poulter was allegedly not wearing his<br />
TLD badge during radiography on that day. It was<br />
estimated that the actual dose he would have received
would have been similar to the dose received by<br />
Mr Mobbs. It may have even been higher as he was<br />
nearer to the source while changing films between<br />
exposures.<br />
The <strong>Radiation</strong> Safety Unit had required that the industrial<br />
radiography equipment used during the incident be<br />
inspected by an independent expert. This showed that the<br />
equipment had been modified. This may have resulted in<br />
the failure of the safety mechanism which allowed the<br />
equipment to be assembled without the source pigtail<br />
being properly connected to the cable.<br />
The Company was instructed to arrange for lymphocyte<br />
counts and chromosome aberration blood tests for the two<br />
operators. The latter tests were carried out by the<br />
National Radiological Protection Board, UK (the tests are<br />
not done in Australia). The results were not conclusive.<br />
The <strong>Committee</strong> advised that Mr Poulter’s operator licence<br />
not be <strong>au</strong>tomatically renewed. Mr Poulter’s operator<br />
licence expired on 27 February 1998 and was not<br />
renewed. Mr Poulter was advised that he would need to<br />
pass the Victorian radiation safety licensing examination<br />
and satisfactorily undergo a practical assessment of his<br />
radiation safety knowledge prior to obtaining a new<br />
licence. (Mr Poulter had previously been exempted from<br />
passing the Victorian examination on the basis of his pass<br />
in the WA licensing examination).<br />
The <strong>Committee</strong> advised that legal ad<strong>vic</strong>e be sought<br />
regarding this incident.<br />
4.6 Transport Incident - Bresatec P/L<br />
On 30 January 1998 the <strong>Radiation</strong> Safety Unit was<br />
advised by Ansett Air Express that a plastic cylinder with<br />
the radiation symbol had been found in one of their freight<br />
handling trolleys. There was no outer packaging or<br />
shipment information with the container. RSU officers<br />
collected the container from Australian Air Express. The<br />
container was embossed with the word Bresatec as well as<br />
having a label indicating that the material was P-32 (1<br />
mCi or 37 MBq). Subsequent investigation indicated that<br />
Bresatec was a South Australian supplier of radio-labelled<br />
materials. Bresatec was contacted and indicated that they<br />
were aware of a missing shipment intended for Baker<br />
Institute in Melbourne. The outer package had been<br />
delivered to Baker Institute punctured and without the<br />
contents.<br />
During the discussion with Bresatec, it was indicated that<br />
the outer container was a cardboard box with a cardboard<br />
insert which held the container in position. Transports<br />
were forwarded as excepted packages with no outer<br />
labelling and were not declared as dangerous goods<br />
The outer package was subsequently collected by RSU<br />
officers. The container was only damaged on the bottom<br />
as if it may have occurred during packing. It is also<br />
possible that it could have been damaged by catching on<br />
the wire sides of the freight trolley.<br />
It should also be noted that the limit for an excepted<br />
package of P-32 is 30 MBq so that the transport should<br />
not have been as an unlabelled excepted package.<br />
24<br />
The SAHC <strong>Radiation</strong> Protection Branch was advised of<br />
the incident and arranged for officers to inspect Bresatec.<br />
SAHC subsequently advised that :<br />
Bresatec had only been using the new packing in 1998.<br />
They were now having a consultant look at the packaging.<br />
Figure 9. Showing Damage to Base of Package<br />
Other type of packaging- styrene- probably still should be<br />
reinforced.<br />
That the labelling of package was substandard as it was<br />
not an excepted package.<br />
The incident involved inadequate packaging of a shipment<br />
which was also inappropriately labelled. The <strong>Committee</strong><br />
Figure 10. Showing vial in package<br />
noted that as the package originated from SA<br />
consideration of further action should be handled by<br />
SAHC.<br />
Bresatec subsequently wrote requesting approval for all of<br />
their transports to be treated as excepted packages. This<br />
request was refused as there is no provision to vary<br />
requirements which are an adoption of international<br />
transport regulations.<br />
4.7 Misadministration of<br />
Radiopharmaceuticals - Alfred<br />
Hospital<br />
Two reports were received from the Alfred Hospital about<br />
incidents where patients had been injected with incorrect<br />
radiopharmaceuticals. In the first case, a patient was<br />
inadvertently injected with 880 MBq of Tc-99m labelled<br />
Medronate (a bone scanning agent) instead of 400 MBq of
Tc-99m MAG3 (renal scanning agent). The previous<br />
patient’s bone flow injection had been postponed at the<br />
last minute. The nuclear medicine registrar came into the<br />
room to administer the renal agent but picked up the bone<br />
scanning agent injection by mistake. The mistake was<br />
realised immediately and the patient was advised of the<br />
error and of the small dose the male 70 year old had<br />
received. The following prec<strong>au</strong>tions were instigated to<br />
avoid a repeat of this type of incident:<br />
(a) If a session is cancelled then the radiopharmaceutical<br />
must be returned to the warm lab for storage before the<br />
next patient can be brought in for treatment.<br />
(b) Only one injection dose can be left on the trolley.<br />
(c) The registrars have been reminded to recheck the<br />
radiopharmaceutical at the time of injection.<br />
In the second case, a patient was referred for a bone scan<br />
on 3 August 1998. The consultant and registrar went to<br />
the ward but the patient was not available at that time.<br />
The registrar returned to the ward later, identified the<br />
patient and injected the patient. It was later discovered to<br />
be the incorrect patient. The patient had the same<br />
surname as indicated on the referral. The error occurred<br />
due to a new registrar’s failure to follow the identification<br />
procedures outlined in the Department’s procedure<br />
manual. The consultant has since reviewed correct patient<br />
identification procedures with the registrar and will ensure<br />
supervision until a satisfactory standard can be<br />
demonstrated. Also, direct supervision will be given to all<br />
new medical registrars for procedures relating to patient<br />
identification at presentation and immediately prior to<br />
injection of a radiopharmaceutical.<br />
The <strong>Committee</strong> noted the reports and considered that the<br />
action taken to prevent recurrence was appropriate.<br />
4.8 Hair Loss following Neuroradiology<br />
Monash Medical Centre reported three cases of hair loss<br />
over a period of about one year, following neuroradiology<br />
procedures. All the patients had been diagnosed with<br />
cerebral aneurysms and had undergone platinum<br />
detachable coil insertion under angiographic control. The<br />
threshold for temporary hair loss is 3 Gy.<br />
The <strong>Committee</strong> reviewed these incidents in some detail<br />
and confirmed that the benefits of the procedure<br />
outweighed the risk of hair loss. The cost of not<br />
undergoing the procedure is a very high probability of<br />
death of the patient.<br />
The <strong>Committee</strong> requested that ad<strong>vic</strong>e of the incidents be<br />
forwarded to the national <strong>Radiation</strong> Health <strong>Committee</strong>.<br />
The <strong>Committee</strong> also requested that an information circular<br />
be developed, giving ad<strong>vic</strong>e on dose reduction techniques<br />
for such procedures.<br />
4.9 Iodine 131 dose to Pregnant Woman -<br />
Monash Medical Centre<br />
A report was received that a woman had received a dose<br />
of 150 MBq of I-131 and one week later had given a<br />
positive pregnancy test. The dose was given following a<br />
25<br />
thyroidectomy to determine if any thyroid tissue was<br />
missed, and so that uptake can be measured and<br />
metastases identified. This information is used to choose<br />
the most appropriate therapeutic dose of iodine-131 for<br />
ablating the remaining thyroid tissue and the metastases.<br />
The pregnancy test was carried out prior to the proposed<br />
therapy dose. When this test was positive the therapy<br />
dose was not administered. The <strong>Committee</strong> had concerns<br />
about the protocol for such procedures and recommended<br />
that the <strong>Radiation</strong> Safety Unit develop an information<br />
circular on this issue.
APPENDIX I<br />
SUMMARY OF DOSES MEASURED IN PATIENT DOSE SURVEYS<br />
Skin entrance dose rate (in air) in mGy/min. to various phantoms from mobile image intensifiers.<br />
The dose rates are at 300 mm from the image receptor plane.<br />
Phantom min. 1st median 3rd max. mean<br />
quartile<br />
quartile<br />
15 cm perspex, 4.5 mm Al 5 9 11 15 45 14<br />
20 cm perspex, 4.5 mm Al 8 15 21 29 45 22<br />
Maximum entrance exposure rate 8 27 38 43 58 35<br />
Skin entrance dose rate (in air) in mGy/min. to various phantoms from fixed fluoroscopy equipment.<br />
The dose rates are at the table top.<br />
Phantom min. 1st median 3rd max. mean<br />
quartile<br />
quartile<br />
15 cm perspex, 4.5 mm Al 4 12 19 22 116 21<br />
15 cm perspex, 4.5 mm Al, 1.6 mm Cu 9 25 48 62 117 47<br />
20 cm perspex, 4.5 mm Al 6 21 35 42 116 35<br />
20 cm perspex, 4.5 mm Al, 1.6 mm Cu 12 40 49 75 117 57<br />
Maximum entrance exposure rate 22 47 66 87 150 67<br />
Skin entrance dose (in air) in mGy from spot film radiography from fixed fluoroscopy equipment<br />
Phantom min. 1st median 3rd max. mean<br />
quartile<br />
quartile<br />
20 cm perspex, 4.5 mm Al 1.5 2.1 3.2 4.6 9.9 3.8<br />
20 cm perspex, 4.5 mm Al, 1.6 mm Cu 3.6 8.0 12.7 15.7 50 13.4<br />
26<br />
Distribution of skin entrance doses in air (µGy) for 1 year old children<br />
Procedure No of Minimum 1st Median 3rd Maximum Mean<br />
Non-Grid<br />
Centres<br />
Quartile<br />
Quartile<br />
Chest (AP) 28 16 26 32 40 66 33<br />
Chest (lat) 23 35 44 54 64 93 58<br />
Abdomen (AP) 20 41 61 76 94 399 99<br />
Pelvis (AP) 21 29 57 78 118 399 118<br />
L spine (AP) 11 57 76 90 132 616 137<br />
L spine (lat) 12 85 120 141 211 932 241<br />
Skull (AP) 13 56 127 144 176 529 174<br />
Skull (lat)<br />
Grid<br />
14 38 70 87 113 266 101<br />
Abdomen (AP) 7 134 153 210 427 783 327<br />
Pelvis (AP) 7 151 156 184 277 499 243<br />
L spine (AP) 12 151 221 438 640 1210 482<br />
L spine (lat) 9 253 348 730 1272 1566 856<br />
Skull (AP) 12 296 439 465 624 972 534<br />
Skull (lat) 12 180 255 343 387 522 334
27<br />
Distribution of skin entrance doses in air (µGy) for 5 year old children<br />
Procedure No of Minimum 1st Median 3rd Maximum Mean<br />
Non-Grid<br />
Centres<br />
Quartile<br />
Quartile<br />
Chest (AP) 27 20 31 37 48 114 43<br />
Chest (lat) 21 44 58 80 97 369 96<br />
Abdomen (AP) 6 50 98 178 102<br />
Pelvis (AP) 5 67 138 446 209<br />
L spine (AP) 3 70 134 446 217<br />
L spine (lat) 2 140 453 766 453<br />
Skull (AP) 4 75 213 366 217<br />
Skull (lat)<br />
Grid<br />
5 66 108 191 118<br />
Chest (AP) 2 42 61 81 61<br />
Chest (lat) 4 82 102 143 107<br />
Abdomen (AP) 23 187 324 499 677 1214 535<br />
Pelvis (AP) 22 164 317 457 676 1102 503<br />
L spine (AP) 23 187 412 710 865 1249 669<br />
L spine (lat) 23 439 675 1316 2221 4011 1560<br />
Skull (AP) 20 399 641 877 1056 1418 869<br />
Skull (lat) 20 229 374 471 510 926 488<br />
Distribution of skin entrance doses in air (µGy) for 10 year old children<br />
Procedure No of Minimum 1st Median 3rd Maximum Mean<br />
Non-Grid<br />
Centres<br />
Quartile<br />
Quartile<br />
Chest (AP/PA) 20 6 32 45 59 146 49<br />
Chest (lat)<br />
Grid<br />
16 33 63 91 140 238 105<br />
Chest (AP/PA) 8 29 43 52 93 122 65<br />
Chest (lat) 10 57 136 193 473 680 291<br />
Abdomen (AP) 25 271 720 1125 1431 1807 1028<br />
Pelvis (AP) 27 271 620 994 1294 1973 989<br />
L spine (AP) 26 271 833 1189 1482 3029 1210<br />
L spine (lat) 25 528 1896 2680 3771 7757 3176<br />
Skull (AP) 24 373 741 1131 1411 2101 1129<br />
Skull (lat) 25 149 484 540 695 879 550<br />
Distribution of skin entrance doses in air (µGy) for 15 year old children<br />
Procedure No of Minimum 1st Median 3rd Maximum Mean<br />
Non-Grid<br />
Centres<br />
Quartile<br />
Quartile<br />
Chest (AP/PA) 12 12 38 47 64 88 49<br />
Chest (lat)<br />
Grid<br />
7 64 107 121 204 253 152<br />
Chest (AP/PA) 16 40 67 85 139 231 105<br />
Chest (lat) 20 113 239 338 435 940 399<br />
Abdomen (AP) 24 463 1366 1782 2216 3242 1731<br />
Pelvis (AP) 25 463 1084 1636 1822 3242 1596<br />
L spine (AP) 24 463 1479 1956 2424 3242 1892<br />
L spine (lat) 23 1493 4126 5652 8832 15404 6727<br />
Skull (AP) 23 598 1096 1413 1660 2924 1481<br />
Skull (lat) 24 299 532 608 875 1139 679
APPENDIX II<br />
GUIDANCE DOSE LEVELS RECOMMENDED FOR USE IN VICTORIA<br />
28<br />
Neonate chest - skin entrance dose (in air) per radiograph (µGy)<br />
1000 g.<br />
2000 g.<br />
3500 g.<br />
Paediatric - skin entrance dose (in air) per radiograph (µGy)<br />
1 year old 5 year old 10 year old 15 year old<br />
Non-grid Grid Non-grid Grid Non-grid Grid Non-grid Grid<br />
Chest (AP/PA) 40 -- 50 -- 60 100 60 150<br />
Chest (lat) 60 -- 100 -- 150 450 200 450<br />
Abdomen (AP) 100 400 -- 700 -- 1400 -- 2000<br />
Pelvis (AP) 125 300 -- 700 -- 1300 -- 1800<br />
Lumbar spine (AP) 125 650 -- 850 -- 1500 -- 2500<br />
Lumbar spine (lat) 200 1250 -- 2200 -- 4000 -- 8800<br />
Skull (AP) 175 600 -- 1000 -- 1400 -- 1600<br />
Skull (lat) 125 400 -- 500 -- 700 -- 900<br />
Adult - skin entrance dose (in air) per radiograph (mGy) - average size patient<br />
50<br />
55<br />
75<br />
chest PA - with grid 0.16<br />
chest PA - no grid 0.11<br />
Fluoroscopy - skin entrance dose rate (in air) (mGy/min) - average size patient<br />
fixed screening unit 42<br />
mobile image intensifier 30<br />
Developed from measurements made using a phantom assembly of 20 cm of perspex and 0.45 cm of aluminium.<br />
CT scanners - CTDIw (in air) (mGy) (Derived from measurements using a 32 cm diameter perspex body phantom & 16 cm<br />
diameter perspex head phantom)<br />
Routine head 58<br />
Routine chest 27<br />
Routine pelvis 33<br />
Routine abdomen 33<br />
Chiropractic Radiography - skin entrance dose (in tissue) (mGy)<br />
Cer<strong>vic</strong>al spine AP 2<br />
Cer<strong>vic</strong>al spine lat 2<br />
Thoracic spine AP 5<br />
Thoracic spine lat 10<br />
Lumbar spine AP 10<br />
Lumbar spine lat 20
APPENDIX III<br />
RESEARCH WITH HUMAN VOLUNTEERS -- PROJECTS APPROVED<br />
29<br />
Licensee Work location Chief<br />
investigator<br />
Project Title<br />
Alfred & Baker Medical William Buckland Cucittini Does oestrogen replacement therapy (ORT) prevent<br />
Research Institute Radiotherapy<br />
osteoarthritis? A study examining the effect or ORT on knee<br />
Centre<br />
cartilage.<br />
Alfred & Baker Medical William Buckland Krum Effect of withdrawal of antihypertensive drug therapy on<br />
Research Institute Radiotherapy<br />
<strong>au</strong>tomatic functions and vascular responsiveness in patients<br />
Centre<br />
with mild to moderate essential hypertension.<br />
Alfred & Baker Medical Baker Medical Esler Effects of brain natriuretic peptide (BNP) on regional<br />
Research Institute Research Institute<br />
sympathetic activity in congestive heart failure.<br />
Alfred & Baker Medical Alfred Hospital Aggarwal Non-invasive assessment of central monoamine turnover in<br />
Research Institute Heart Centre<br />
heart failure using SPECT-MIBG scanning.<br />
Austin Hospital Austin &<br />
Repatriation<br />
Medical Centre<br />
Seeman Low peak volumetric density bone loss and osteoporosis<br />
Austin Hospital Austin &<br />
Seeman The role of parathyroid hormone in the pathogenesis of<br />
Repatriation<br />
osteoporosis: study of age related bone loss in patients with<br />
Medical Centre<br />
primary hyperparathyroidism and secondary<br />
hypoparathyroidism.<br />
Monash Medical Centre Monash Medical<br />
Centre<br />
Carey Cerebral re-organisation following stroke recovery<br />
Monash Medical Centre Austin Hospital Donnan Cortical re-organisation and sensory-motor recovery after<br />
PET lab.<br />
stroke.<br />
Monash Medical Centre Monash Medical Davis Diet and Exercise Intervention to Reverse Polycystic Ovary<br />
Centre<br />
Syndrome<br />
Monash Medical Centre Monash Medical Freezer Effect of Salmeterol/Fluticasone Propionate Combination in<br />
Centre<br />
COPD patients<br />
Monash Medical Centre Monash Medical Kerr Evaluation of the effect of early intervention with epoietin<br />
Centre<br />
alpha in predialysis patients.<br />
Monash Medical Centre Monash Medical<br />
Centre<br />
Cvejic Coordination of breathing and swallowing in COAD patients<br />
Monash Medical Centre Prince Henry's Davis OGEN/PREMARIN/PROVERA - a study of the effects of three<br />
Institute of<br />
different regimens of continuous hormone replacement therapy<br />
Medicine<br />
(HRT)<br />
Monash Medical Centre Monash Medical Meredith Small artery stent study: clinical and angiographic outcome<br />
Centre<br />
following NIR stent implantation in small coronary arteries.<br />
Monash Medical Centre Monash Medical Meredith Stenting of long coronary lesions. a quantitative angiographic<br />
Centre<br />
study using ACS multi-link stents.<br />
Monash Medical Centre Monash Medical Gilfillan The determinants of hip fracture risk - A 12 year follow up of<br />
Centre<br />
2000 post-menop<strong>au</strong>sal women.<br />
Monash Medical Centre Adolescent Medical Clarke The effects of oestrogen replacement on bone mineral density<br />
Unit<br />
in adolescent females with anorexia nervosa.<br />
Royal Melbourne Institute Bundoora, Dept of Rich Bone density & impact exercise in adult female swimmers<br />
of Technology<br />
Anatomy<br />
Royal Melbourne Institute Bundoora, Dept of Rich Establishment of reliability in the use of dual energy x-ray<br />
of Technology<br />
Anatomy<br />
absorptiometry (DEXA)<br />
University of Melbourne St Vincent’s Ng Comparison of Raloxifene HCL and Placebo in the Treatment<br />
Hospital<br />
of Postmenop<strong>au</strong>sal Women with Osteoporosis. The dementia<br />
diagnostic evaluation amendment.<br />
University of Melbourne Department of Hargreaves Effect of carbohydrate ingestion on glucose kinetics during<br />
(Dept. of Physiology) Physiology<br />
prolonged exercise
APPENDIX IV(a)<br />
CATEGORY<br />
30<br />
NUMBERS OF OPERATOR LICENCES AS AT 21 Sep 1998<br />
IRRADIATING SEALED UNSEALED ENDORSED<br />
Status Status Status Status<br />
A P T A P T A P T A P T<br />
Radiologists 194 1 — — — — — — 1 48 — —<br />
Medical Imaging Technologists 397 — — — — — — — — — — —<br />
<strong>Radiation</strong> Oncologists 1 — — 1 — — — — — 33 2 —<br />
<strong>Radiation</strong> Therapists 4 — — — — — — — — 25 — —<br />
Nuclear Medicine Specialists — — — — — — 24 — — 1 — —<br />
Nuclear Medicine Technologists — — — — — — 30 — 4 1 — —<br />
General Practitioners 409 — 13 — — — — — — — — —<br />
Dentists 1946 8 2 — — — — — — — — —<br />
Chiropractors 264 2 — — — — — — — — — —<br />
Dermatologists 8 — — — — — — — — — — —<br />
Ophthalmologists — — — 19 — — — — — 2 — —<br />
Other Medical Specialists 27 — 56 — — — 7 — 1 — — —<br />
Dental Therapists 158 1 — — — — — — — — — —<br />
Testers 29 — 2 2 3 2 — —<br />
—<br />
26 1 1<br />
Ser<strong>vic</strong>e Technicians 165 1 1 40 — — — — — 25 1 —<br />
Research (Human Volunteers) 35 3 3 2 — — 12 — — 4 — —<br />
Veterinary Surgeons 540 2 1 — — — — — 1 17 — —<br />
Industrial Radiographers 112 2 14 2 — 1 — — — 174 1 —<br />
Consultants — — — 1 — 2 — — 2 11 — —<br />
Dental Hygienists 42 2 — — — — — — — — — —<br />
Cardiologists 24 — 13 — — — — — — — — 1<br />
Borehole Loggers — — — 37 2 — — — — 5 — —<br />
Moisture/density G<strong>au</strong>ge Operators — — — 271 6 18 — — — — — —<br />
Other Paramedical 11 — — 1 — — 5 — — — — —<br />
Radiologist/Nuclear Medicine Specialist — — — — — — — — — 4 — —<br />
Multiple Category 1 — — — — — — — — — — —<br />
Subtotal 4367 22 105 376 11 23 78 0 9 376 5 2<br />
TOTALS A status: 5197 P status: 38 T status: 139<br />
A status = approved licence<br />
P status = licence to be issued pending payment<br />
T status = applications not yet approved - temporary status<br />
Notes: Endorsed licences are licences which permit use of more than one category of irradiating apparatus, sealed source, and unsealed source on the one licence.<br />
Licences for Medical Imaging Technologists, <strong>Radiation</strong> Therapists, and Nuclear Medicine Technologists are progressively being removed as they expire.<br />
These technologists are now required to be registered with the Medical <strong>Radiation</strong> Technologists Board instead of holding a licence.
APPENDIX IV(b)<br />
CATEGORY<br />
31<br />
NUMBERS OF REGISTRATIONS AS AT 21 Sep 1998<br />
IRRADIATING SEALED<br />
Status Status<br />
A P T A P T<br />
Radiology (Hospital) 455 3 — — — —<br />
Radiology (Private) 484 4 1 — — —<br />
CT Scanner 106 3 1 — — —<br />
Linear Accelerator 24 — 1 — — —<br />
Radiotherapy 11 — — 26 — —<br />
Dermatology 4 — — 1 — —<br />
Ophthalmology — — — 19 — —<br />
Dental 1941 18 6 — — —<br />
Chiropractor 83 — — — — —<br />
Medical (GP) 94 — 1 — — —<br />
X-ray Analysis 95 — — — — —<br />
Irradiation Cell — — — 3 — —<br />
Borehole Logging 2 — — 59 5 —<br />
<strong>Radiation</strong> G<strong>au</strong>ge 10 2 — 453 5 2<br />
Moisture/Density Meter — — — 170 2 —<br />
Industrial Radiography 87 — — 43 — —<br />
Veterinary 369 1 4 7 — —<br />
Calibration — — — 134 1 —<br />
Teaching 16 — — 104 — —<br />
Other Industrial 35 — — 237 1 —<br />
Research 7 — 1 30 1 1<br />
Other Medical 7 — — 5 — —<br />
Mammography 142 1 2 — — —<br />
OPG/Cephalometric 227 — 3 — — —<br />
Cyclotron 1 — — — — —<br />
Bone Mineral Densitometry 38 — — — — —<br />
Mobile Image Intensifier 52 2 — — — —<br />
Condensor Discharge Units 29 3 — — — —<br />
Laboratory Irradiator — — — 8 — —<br />
Lithotripter 3 — — — — —<br />
Crawler Guide Sources — — — 1 — —<br />
Veterinary Dental 6 — — — — —<br />
Therapy Simulator 3 — — — — —<br />
Cabinet X-ray Equipment 37 — 1 — — —<br />
GC-Electron Capture Detector — — — 27 — 1<br />
Subtotal 4368 37 21 1327 15 4<br />
TOTALS A status: 5695 P status: 52 T status: 25<br />
A status = approved registration<br />
P status = registration to be issued pending payment<br />
T status = applications not yet approved - temporary status
APPENDIX IV(c)<br />
CATEGORY<br />
32<br />
NUMBERS OF MANAGEMENT LICENCES AS AT 21 Sep 1998<br />
IRRADIATING SEALED UNSEALED ENDORSED TRANSPORT<br />
Status Status Status Status Status<br />
A P T A P T A P T A P T A P T<br />
Sales 48 1 4 61 — 3 16 — — 12 — —<br />
Industrial — — — — — — 12 — — — — —<br />
Hospital — — — — — — 17 — — — — —<br />
Pathology — — — — — — 9 — — — — —<br />
Education and Research — — — — — — 36 1 — — — —<br />
Research with Human<br />
Volunteers<br />
7 — — 1 — — 5 — — 2 — —<br />
Radiotherapy — — — — — — 2 — — — — —<br />
Nuclear Medicine — — — — — — 43 — — — — —<br />
Other Medical — — — — — — 1 — — — — —<br />
Government Departments — — — — — — 13 — — — — —<br />
Veterinary — — — — — — 5 — 2 — — —<br />
Other Laboratory — — — — — — 2 — — — — —<br />
Manufacturer 1 — — — — — — — — — — —<br />
Transport 15 — —<br />
Transport (Low Level<br />
Waste)<br />
7 — —<br />
Subtotal 56 1 4 62 0 3 161 1 2 14 0 0 22 0 0<br />
TOTALS A status: 315 P status: 2 T status: 9<br />
A status = approved licence<br />
P status = licence to be issued pending payment<br />
T status = applications not yet approved - temporary status<br />
Notes: Endorsed licences are licences which permit use of more than one category of irradiating apparatus, sealed source, and unsealed source on the one licence.
33<br />
APPENDIX V<br />
Summary of <strong>Radiation</strong> Safety Testing - May 1984 to September 1998<br />
Type Total Number Inspected % Inspected<br />
61 (Public Hospital) 456 344 75.4<br />
62 (Private Radiology) 492 208 42.3<br />
63 (CT Scanners) 110 42 38.2<br />
64 (Linear Accelerators) 25 6 24.0<br />
65 (Radiotherapy - X-ray) 11 3 27.3<br />
65 (Radiotherapy - Sources) 26 5 19.2<br />
66 (Dermatology - X-ray) 4 1 25.0<br />
66 (Dermatology - Source) 1 1 100.0<br />
67 (Ophthalmology) 19 14 73.7<br />
68 (Dentists) 1965 929 47.3<br />
69 (Chiropractor) 83 66 79.5<br />
70 (General Practitioners) 95 81 85.3<br />
71 (X-ray Analysis) 96 18 18.8<br />
72 (Irradiation Cells) 3 1 33.3<br />
73 (Borehole Logging) 65 9 13.8<br />
74 (G<strong>au</strong>ges - X-ray) 12 2 16.7<br />
74 (G<strong>au</strong>ges - Sources) 462 210 45.5<br />
75 (Nuclear Moisture G<strong>au</strong>ges) 172 117 68.0<br />
76 (Industrial Radiography - X-ray) 87 35 40.2<br />
76 (Industrial Radiography - Sources) 43 11 25.6<br />
77 (Veterinary - X-ray) 374 144 38.5<br />
77 (Veterinary - Sources) 7 6 85.7<br />
78 (Calibration Sources) 135 6 4.4<br />
79 (Teaching - X-ray) 16 2 12.5<br />
79 (Teaching - Sources) 104 2 1.9<br />
80 (Other Industrial - X-ray) 35 15 42.9<br />
80 (Other Industrial - Sources) 238 24 10.1<br />
81 (Research - X-ray) 8 2 25.0<br />
81 (Research - Sources) 32 1 3.1<br />
82 (Other Medical - X-ray) 7 4 57.1<br />
82 (Other Medical - Sources) 5 3 60.0<br />
83 (Mammography) 145 101 69.7<br />
84 (OPG) 232 85 36.6<br />
85 (Medical Cyclotron) 1 0 0.0<br />
86 (Bone Mineral Densitometers) 40 10 25.0<br />
87 (Mobile Image Intensifiers) 54 15 27.8<br />
88 (Condensor Discharge Mobile) 32 14 43.8<br />
89 (Laboratory Irradiators) 8 6 75.0<br />
90 (Lithotripter) 3 1 33.3<br />
91 (Industrial Radiography Crawler Guide Sources) 1 0 0.0<br />
92 (Veterinary Dental) 6 1 16.7<br />
93 (Therapy Simulator) 3 1 33.3<br />
94 (Cabinet X-ray Equipment) 38 12 31.6<br />
95 (GC-Electron Capture Detectors) 28 0 0.0<br />
Totals 5779 2558 44.3<br />
NB: This list only applies to units registered (or for which applications have been made) at the time of preparation of this summary. It does not take account of units<br />
that were inspected and have subsequently been de-registered through being sold, dismantled, destroyed or placed in storage.
APPENDIX VI<br />
SUMMARY OF TRAINING COURSES AND EXAMINATIONS IN RADIATION SAFETY<br />
Summary of <strong>Radiation</strong> Safety Courses - 1991 to September 1998<br />
34<br />
Course No of Courses No of Attendees<br />
97/98 Total Since<br />
Inception<br />
Individuals Companies<br />
97/98 Since<br />
Inception<br />
97/98 Since<br />
Inception<br />
Industrial <strong>Radiation</strong> G<strong>au</strong>ges 2 19 12 216 13 82<br />
Nuclear Moisture/Density G<strong>au</strong>ges 2 14 18 121 6 56<br />
Unsealed Source Laboratory 0 4 0 43 0 10<br />
Transport 0 10 0 78 0 18<br />
General Practitioner Radiography 1 11 17 243 N/A<br />
Summary of <strong>Radiation</strong> Safety Examinations - 1986 to September 1998<br />
Examination No of Examinations Examination Details<br />
<strong>Radiation</strong> Protection in Industrial<br />
Radiography<br />
<strong>Radiation</strong> Protection in Industrial<br />
X-radiography<br />
<strong>Radiation</strong> Protection in Fixed<br />
Enclosure Industrial Radiography<br />
Sites<br />
97/98 Total Since<br />
Inception<br />
97/98 Since Inception<br />
Attempts Passes Attempts Passes<br />
7 59 16 12 433 283<br />
1 7 1 1 23 22<br />
3 11<br />
Nuclear Moisture/Density G<strong>au</strong>ges 10 33 67 59 327 278<br />
9<br />
8<br />
35<br />
23
APPENDIX VII<br />
35<br />
PAPERS RELATED TO BIOLOGICAL EFFECTS ASSOCIATED WITH POWER FREQUENCY<br />
ELECTROMAGNETIC FIELDS CONSIDERED IN THE PAST YEAR<br />
1. Animal Studies<br />
Ekstrom T, Mild KH, Holmberg B. Mammary tumours in<br />
Sprague-Dawley rats after initiation with DBMA followed by<br />
exposure to 50-Hz electromagnetic fields in a promotional<br />
scheme. Cancer Letters 1998:. 123: 107-111<br />
Harris AW, Basten A, Gebski V, Noonan D et al. A test of<br />
lymphoma induction by long-term exposure of E-Pim 1<br />
transgenic mice to 50 Hz magnetic fields. <strong>Radiation</strong> Research<br />
1998; 149: 300 - 307.<br />
Kumlin T, Kosma VM, Alhonen L, Jänne J et al. Effects of<br />
50-Hz magnetic fields on UV-induced skin tumourigenesis in<br />
ODC-transgenic and non-transgenic mice. Int J Radiat Biol<br />
1998: 73:113-121.<br />
Lai H, Carino MA, Ushijima I. Acute exposure to a 60-Hz<br />
magnetic field affects rats' water-maze performance.<br />
Bioelectromagnetics 1998: 19: 117-122<br />
Mandeville R, Franco E, Sidrac-Ghali S, Paris-Nadon L et al.<br />
Evaluation of the potential carcinogenicity of 60-Hz linear<br />
sinusoidal continuous wave magnetic fields in Fischer F344<br />
rats. FASEB Journal 1997; 11: 1127 - 1136.<br />
Reiter RJ, Tan DX, Poeggeler B, Kavet R. Inconsistent<br />
suppression of nocturnal pineal melatonin synthesis and serum<br />
melatonin levels in rats exposed to DC magnetic fields.<br />
Bioelectromagnetics 1998: 19: 318-329<br />
Sastre A, Cook MR, Graham C. Nocturnal exposure to<br />
intermittent 60 Hz magnetic fields alters human cardiac<br />
rhythm. Bioelectromagnetics 1998; 19: 98 - 106.<br />
Sinkiewicz ZJ, Haylock RG, S<strong>au</strong>nders RD. Deficits in spatial<br />
learning after exposure of mice to a 50-Hz magnetic field.<br />
Bioelectromagnetics 1998: 19: 79-84<br />
Wood AW, Armstrong SM, Sait ML, Devine L, Martin MJ.<br />
Changes in human plasma melatonin profiles in response to 50<br />
Hz magnetic field exposure. J Pineal Res 1998: 25: 116-127<br />
Yasui M, Kikuchi T, Ogawa M, Tsuchitani M and Iwata H.<br />
Carcinogenicity test of 50 Hz Sinusoidal Magnetic Fields in<br />
Rats. Bioelectromagnetics 1997; 18: 531 - 540.<br />
Zecca L, Mantegazza C, Margonato V, Cerretelli P et al.<br />
Biological effects of prolonged exposure to ELF<br />
electromagnetic fields in rats: III. 50-Hz electromagnetic<br />
fields. Bioelectromagnetics 1998: 19: 57-66<br />
2. Cell Studies<br />
Dibirdik I, Kristupaitis D, Kurosaki T, Tuel-Ahlgren L et al.<br />
Simulation of Src family protein-tyrosine kinases as a<br />
proximal and mandatory step for SYK kinase-dependent<br />
phospholipase Cγ2 activation in lymphoma B cells exposed to<br />
low energy electromagnetic fields. J Bio Chem 1998; 273:<br />
4035-4039<br />
Rosen LA, Barber I, Lyle DB. A 0.5 G, 60-Hz magnetic field<br />
suppresses melatonin production in pinealocytes.<br />
Bioelectromagnetics 1998: 19: 123-127.<br />
3. Epidemiology<br />
Dockerty JD, Elwood JM, Skegg DC, Herbison GP.<br />
Electromagnetic field exposures and childhood cancers in<br />
New Zealand. Cancer C<strong>au</strong>ses & Control 1998: 9: 299-310<br />
Feychting M, Pedersen NL, Svedberg P, Floderus B and Gatz<br />
M. Dementia and occupational exposure to magnetic fields.<br />
Scand J Work Environ Health 1998; 24: 46 - 53.<br />
Feychting M, Svensson D and Ahlbom A. Exposure to motor<br />
vehicle exh<strong>au</strong>st and childhood cancer. Scand J Work Environ<br />
Health 1998; 24: 8 - 11.<br />
Johansen C and Olsen JH. Risk of cancer among Danish<br />
utility workers - a nationwide cohort study. An J Epidemiol<br />
1998; 147: 548 - 555.<br />
Li C-Y, Lee W-C and Lin RS. Risk of leukemia in children<br />
living near high-voltage transmission lines. JOEM 1998; 40:<br />
144 - 147.<br />
Michaelis J, Schuz J, Meinert R, Zemann E et al. Combined<br />
risk estimates for two German population-based case-control<br />
studies on residential magnetic fields and childhood acute<br />
leukaemia. Epidemiology 1998; 9: 92 - 94.<br />
Théri<strong>au</strong>lt G and Li C-Y. Risks of leukaemia among residents<br />
close to high voltage transmission electric lines. Occup<br />
Environ Med 1997; 54: 625 - 628.<br />
Törnqvist S. Paternal work in the power industry: effects on<br />
children at delivery. JOEM 1998; 40: 111 - 117.<br />
4. Dosimetry<br />
Skotte JH and Hjøllund HI. Exposure of welders and other<br />
metal workers to ELF magnetic fields. Bioelectromagnetics<br />
1997; 18: 470 - 477.<br />
Wenzl TB. Estimating magnetic field exposures of rail<br />
maintenance workers. AIHA Journal 1997; 58: 667 - 671.
5. Reviews and Editorials<br />
Portier CJ, Wolfe MS (Eds.). Assessment of <strong>health</strong> effects<br />
form exposure to power-line frequency electric and magnetic<br />
fields: NIEHS Working Group <strong>Report</strong>. <strong>Report</strong> No. 98-3981.<br />
Research Triangle Park, NC: US National Institute of<br />
Environmental Health Sciences.<br />
US National Institute of Environmental Health Sciences.<br />
<strong>Report</strong> from Director (in press)<br />
6. International Guidelines<br />
International Commission on Non-ionizing <strong>Radiation</strong><br />
Protection. Guidelines for limiting exposure to time-varying<br />
electric, magnetic and electromagnetic fields (up to 300 GHz).<br />
Health Physics April 1998; 74(4): 494-522.<br />
36<br />
7. Other<br />
Linet MS, Tarone and Robison LL. Leukemia and exposure to<br />
magnetic fields. N Engl J Med 1997; 337(20): 1473-1474.<br />
Neutra RR. Leukemia and exposure to magnetic fields. N<br />
Engl J Med 1997; 337(20): 1473.<br />
Stevens RG. Leukemia and exposure to magnetic fields. N<br />
Engl J Med 1997; 337(20): 1471-1472.<br />
Wartenberg D. Leukemia and exposure to magnetic fields. N<br />
Engl J Med 1997; 337(20): 1471.<br />
Zaffanella LE, Savitz DA, Greenland S and Ebi KL. The<br />
residential case-specular method to study wire codes, magnetic<br />
fields and disease. Epidemiology 1998; 9: 16-20.
37<br />
APPENDIX VIII SUMMARY OF EPIDEMIOLOGICAL PAPERS (1997-1998)<br />
Measure of Exposure Results Comments<br />
Result based on 9 cases<br />
and 8 controls<br />
OR = 2.3 (95% CI<br />
0.8 - 6.5) for exposures<br />
above a median of 0.2 T<br />
OR for all cancers = 1.06<br />
(1.03 - 1.10). No excess<br />
for leukemia, brain<br />
cancer or breast cancer<br />
(male or female)<br />
Authors Country Year Type of Study Subjects Health<br />
Published<br />
Outcome<br />
Michaelis et Germany 1998 Pooling of two 176 cases<br />
Childhood 24 hr bedroom<br />
al<br />
previous<br />
414 controls leukemia measurements<br />
case-control studies<br />
Johansen Denmark 1998 Cohort study 32 006 employees All cancers Job-exposure matrix<br />
and Olsen<br />
involving all 99<br />
partly constructed using<br />
Danish utilities<br />
a 1993 personal<br />
dosimeter survey<br />
Exposure assessment was<br />
not very detailed. Main<br />
contribution to OR for<br />
all cancers mainly due to<br />
pleural and lung cancer<br />
(which seems to be due<br />
to asbestos), non<br />
melanoma skin cancer<br />
and gall bladder cancer<br />
Poor measure of<br />
exposure. SIRs based on<br />
small numbers in each<br />
age group (2, 4 and 1<br />
respectively)<br />
All ORs were<br />
approximately 1.5.<br />
Whilst this is a<br />
meta-analysis, these are<br />
nevertheless small<br />
numbers. Provides some<br />
support for an<br />
association between<br />
leukaemia and proximity<br />
to high voltage<br />
transmission lines<br />
1 - large numbers but<br />
crude exposure<br />
information<br />
2 - Better exposure<br />
information but small<br />
numbers<br />
Significantly elevated<br />
SIR in 0 - 4 and 5 - 9<br />
year old age groups but<br />
not 10 - 14 year old age<br />
Residence within 100 m<br />
of high tension<br />
powerlines<br />
Childhood<br />
leukemia<br />
120 696 children<br />
residing in Taipei<br />
Li et al Taiwan 1998 Observational Study<br />
(SIR)<br />
group<br />
Combined ORs<br />
significantly elevated for<br />
cut-off distances of 25 m<br />
and 50 m, and for all<br />
calculated magnetic field<br />
cut-off points other than<br />
2 mG (95 % CI includes<br />
unity)<br />
Leukemia 1 - Distance from high<br />
tension powerlines<br />
(> 49 kV)<br />
2 - Calculated magnetic<br />
fields from lines<br />
Various 1997 Meta-Analysis Residents close to<br />
high voltage<br />
transmission lines<br />
Théri<strong>au</strong>lt<br />
and Li<br />
No significantly elevated<br />
risk of any of the <strong>health</strong><br />
outcomes other than the<br />
number of cancers in<br />
study 1 being higher than<br />
that expected compared<br />
with the general<br />
population. NB. no<br />
difference between<br />
“exposed” and<br />
“unexposed” groups<br />
1 - classified as electrical<br />
worker in census<br />
2 - Average exposure<br />
based on 278 full shift<br />
measurements for work<br />
tasks and estimation of<br />
time spent on various<br />
tasks<br />
Birth outcome<br />
and cancer in<br />
the offspring of<br />
fathers<br />
1 - Men with<br />
occupations in the<br />
power industry<br />
2 - First-employed<br />
power industry<br />
workers<br />
Törnqvist Sweden 1998 1 - Retrospective<br />
cohort study<br />
2 - Prospective<br />
cohort study
38<br />
Measure of Exposure Results Comments<br />
24 hr residential<br />
measurements<br />
Authors Country Year Type of Study Subjects Health<br />
Published<br />
Outcome<br />
Dockerty et New 1998 Case-control 303 cases and 303 Childhood<br />
al<br />
Zealand<br />
controls<br />
leukemia<br />
This is a small study and<br />
multiple comparisons<br />
were made. The positive<br />
findings should be<br />
interpreted c<strong>au</strong>tiously<br />
Some ORs slightly but<br />
not significantly<br />
elevated. For the highest<br />
category of bedroom<br />
magnetic field the OR<br />
was high (15.5) but had a<br />
wide confidence interval<br />
(1.1 - 224) due to small<br />
Results only partially<br />
support findings by<br />
previous studies that<br />
indicate that<br />
occupational magnetic<br />
field exposure may<br />
possibly influence the<br />
development of dementia<br />
numbers<br />
- ORs close to unity for<br />
last occupation<br />
- ORs close to unity for<br />
reference group 1 and<br />
slightly raised (but not<br />
significantly) for group 2<br />
in the case of highest<br />
exposure occupation<br />
- ORs significantly<br />
elevated for both<br />
dementia and<br />
Alzheimer’s disease with<br />
both groups (ORs range<br />
from 2.4 to 3.8<br />
- Significantly elevated<br />
risk for total cancer only<br />
at highest exposure level<br />
- Elevated risks for<br />
leukemia and central<br />
nervous systems were<br />
not significant and had<br />
wide confidence<br />
intervals<br />
Job-exposure matrix for<br />
primary occupation, last<br />
occupation and<br />
occupation with highest<br />
magnetic field exposure<br />
Dementia <br />
mainly<br />
Alzheimer’s<br />
disease<br />
Sweden 1998 Case-control 77 cases and two<br />
reference groups<br />
with 228 and 238<br />
persons respectively<br />
Feychting<br />
et al<br />
The <strong>au</strong>thors conclude<br />
that their results indicate<br />
an association between<br />
childhood cancer and<br />
motor vehicle exh<strong>au</strong>st<br />
although the number of<br />
cases was small. Motor<br />
vehicle exh<strong>au</strong>st is one<br />
possible confounder in<br />
residential ELF<br />
epidemiologic studies<br />
Nitrogen dioxide<br />
concentration was used<br />
as a measure of motor<br />
vehicle exh<strong>au</strong>st<br />
Childhood<br />
cancer (from<br />
exposure to<br />
motor vehicle<br />
exh<strong>au</strong>st)<br />
142 cases from a<br />
cohort of 127 000<br />
people living within<br />
300 m of<br />
transmission lines,<br />
and 4 referents per<br />
case from the cohort<br />
Sweden 1998 Nested<br />
Case-Control<br />
Feychting<br />
et al
APPENDIX IX<br />
39<br />
PAPERS RELATED TO BIOLOGICAL EFFECTS ASSOCIATED WITH RADIOFREQUENCY<br />
RADIATION CONSIDERED IN THE PAST YEAR<br />
Davidson JA. Brain tumours and mobile phones? (letter).<br />
MJA 5 January, 1998; 168: 48.<br />
de Seze R, Fabbro-Paray P, Miro L. GSM radiocellular<br />
telephones do not disturb the secretion of antepituitary<br />
hormones in humans. Bioelectromagnetics 1998: 19: 271-278<br />
Donnellan M, McKenzie DR, French PW. Effects of exposure<br />
to electromagnetic radiation at 835 MHz on growth,<br />
morphology and secretory characteristics of a mast cell<br />
analogue, RBL-2H3. Cell Biol Internl 1997: 21:427-439.<br />
French PW, Donnellan M, McKenzie DR. Electromagnetic<br />
radiation at 835 MHz changes the morphology and inhibits<br />
proliferation of a human astrocytoma cell line. Bioelectrochem<br />
. Bioenergetics 1997: 43:13-18<br />
International Commission on Non-Ionizing <strong>Radiation</strong><br />
Protection. Guidelines for limiting exposure to time-varying<br />
electric, magnetic and electromagnetic fields (up to 300 GHz).<br />
Health Physics April 1998; 74(4): 494 - 522.<br />
Malyapa RS, Ahern EW, Str<strong>au</strong>be WL, Moros EG et al.<br />
Measurement of DNA damage after exposure to<br />
electromagnetic radiation in the cellular phone communication<br />
frequency band (835.62 and 847.74 MHz. Radiat Research<br />
1997: 148: 618-627<br />
Mann K, Wagner P, Brunn G, Hassan F et al. Effects of pulsed<br />
high-frequency electromagnetic fields on the neuroendocrine<br />
system. Neuroendocrinol 1998: 67: 139-144<br />
McKenzie DR, Yin Y, Morell S. Childhood incidence of acute<br />
lymphoblastic leukaemia and exposure to broadcast radiation<br />
in Sydney: a second look. Aust NZ J Public Health 1998: 22:<br />
360-367<br />
Schönborn F, Burkhardt M and Kuster N. Differences in<br />
energy absorption between heads of adults and children in the<br />
near field of sources. Health Physics 1998; 74(2): 160 - 168.<br />
Wagner P, Röschke J, Mann W, Frank C. Human sleep under<br />
the influence of pulsed radiofrequency electromagnetic fields:<br />
a polysomnographic study using standardised conditions.<br />
Bioelectromagnetics 1998: 19: 199-202
ABBREVIATIONS<br />
A/m<br />
amps/metre, a unit of magnetic field<br />
AECB<br />
Atomic Energy Control Board (Canada)<br />
AIR<br />
Australian Institute of Radiography<br />
AMA<br />
Australian Medical Association<br />
ANSTO<br />
Australian Nuclear Science and Technology Organisation<br />
ANZAPNM<br />
Australian and New Zealand Association of Physicians in<br />
Nuclear Medicine<br />
ANZSNM<br />
Australian and New Zealand Society of Nuclear Medicine<br />
AP<br />
antero-posterior<br />
ARA<br />
Australian Rheumatology Association<br />
ARPANSA<br />
Australian <strong>Radiation</strong> Protection and Nuclear Safety Agency<br />
Bq<br />
becquerel, a unit of radioactivity (1 Bq = 1 disintegration per<br />
second)<br />
CT<br />
computed tomography<br />
DAP<br />
dose area product<br />
DMBA<br />
dimethylbenz[a]anthracene<br />
DNA<br />
deoxyribonucleic acid<br />
40<br />
DNRE<br />
Department of Natural Resources and Environment<br />
DOELAP<br />
Department of Energy Laboratory Accreditation Program (US)<br />
DPIE<br />
Department Primary Industry and Energy<br />
EMF<br />
electromagnetic field<br />
EMROC<br />
East Melbourne <strong>Radiation</strong> Oncology Centre<br />
GHz<br />
gigahertz, a unit of frequency<br />
(1 GHz=1,000,000,000 Hz)<br />
H&SE<br />
Health & Safety Executive (UK)<br />
Hz<br />
hertz, a unit of frequency<br />
(1 Hz = 1 cycle/second)<br />
ICNIRP<br />
International Commission on Non-ionizing <strong>Radiation</strong><br />
Protection<br />
ICRP<br />
International Commission on Radiological Protection<br />
kBq<br />
kilobecquerel (1 kBq = 1,000 Bq)<br />
kV<br />
kilovolt (1 kV = 1,000 V)<br />
kV/m<br />
kilovolt/metre, a unit of electric field<br />
MAG<br />
metal active gas welding
MBq<br />
megabecquerel (1 MBq = 1,000,000 Bq)<br />
MIG<br />
metal inert gas welding<br />
MIT<br />
medical imaging technologist<br />
µGy<br />
microgray, a unit of absorbed dose<br />
(1 µGy = 0.000 001 Gy)<br />
µSv<br />
microsievert, a unit of equivalent dose<br />
(1 µSv = 0.000 001 Sv)<br />
µT<br />
microtesla, a unit of magnetic flux density<br />
(1 µT = 10 mG)<br />
mG<br />
millig<strong>au</strong>ss, a unit of magnetic flux density<br />
(1 mG = 0.001 G)<br />
mSv<br />
millisievert, a unit of equivalent dose<br />
(1 mSv =0.001 Sv)<br />
mT<br />
millitesla, a unit of magnetic flux density<br />
(1 mT = 10 G)<br />
MRTB<br />
Medical <strong>Radiation</strong> Technologists Board<br />
NHMRC<br />
National Health & Medical Research Council<br />
NIEHS<br />
National Institute of Environmental Health Sciences (US)<br />
NMT<br />
nuclear medicine technologist<br />
NMDG<br />
nuclear moisture/density g<strong>au</strong>ge<br />
41<br />
NRPB<br />
National <strong>Radiation</strong> Protection Board (UK)<br />
NSQAC<br />
National Specialist Qualification <strong>Advisory</strong> <strong>Committee</strong><br />
NVLAP<br />
National Voluntary Laboratory Accreditation Program (US)<br />
OR<br />
odds ratio, the odds of disease in exposed persons divided by<br />
the odds of disease in unexposed persons. An odds ratio of 1<br />
means that there is no difference in risk of disease between<br />
exposed and unexposed persons.<br />
PA<br />
postero-anterior<br />
QA<br />
Quality Assurance<br />
RAC<br />
<strong>Radiation</strong> <strong>Advisory</strong> <strong>Committee</strong><br />
RACGP<br />
Royal Australian College of General Practitioners<br />
RACP<br />
Royal Australasian College of Physicians<br />
RACR<br />
Royal Australasian College of Radiologists<br />
REM<br />
rapid eye movement<br />
RFR<br />
radiofrequency radiation<br />
RMIT<br />
Royal Melbourne Institute of Technology<br />
RSU<br />
<strong>Radiation</strong> Safety Unit, Dept. of Human Ser<strong>vic</strong>es<br />
RVEEH<br />
Royal Victorian Eye & Ear Hospital
TLD<br />
SAHC thermoluminescent dosimeter<br />
South Australian Health Commission<br />
VIG<br />
Sv Victorian Imaging Group<br />
sievert, the special name given to the equivalent and effective<br />
dose unit, J kg -1<br />
TBq<br />
terabecquerel (1 TBq = 1,000,000,000,000 Bq)<br />
42<br />
V/m<br />
volts/metre, a unit of electric field
43<br />
RADIATION ADVISORY COMMITTEE ANNUAL REPORT<br />
RADIATION ADVISORY COMMITTEE<br />
C/- RADIATION SAFETY UNIT<br />
DEPARTMENT OF HUMAN SERVICES<br />
17th Floor<br />
120 Spencer Street<br />
Melbourne 3000<br />
Victoria<br />
Telephone: 61 3 9637 4169<br />
Facsimile: 61 3 9637 4508<br />
email: caroline.isakow@dhs.<strong>vic</strong>.<strong>gov</strong>.<strong>au</strong>